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Abstract 
Toxoplasma gondii is a significant human and animal parasite with worldwide occurrence. The 
population structure and prevalence in definitive hosts and intermediate hosts has been well 
studied in a number of regions including North and South America and Europe. While 
Toxoplasma gondii has been previously reported in a number of mammalian species in 
Australia, there is a surprising lack of information regarding the population structure of T.gondii 
in Australia and current rates of exposure in domestic companion animal hosts.  
 
Members of the felidae family are the only known definitive host of T. gondii  in which sexual 
reproduction of the parasite occurs.Sexual reproduction results in shedding of  environmentally 
resillient oocysts in faeces. All strains of T. gondii  can be traced back to a feline host. As such, an 
understanding of T. gondii infection among feline hosts is an important first step to 
understanding general prevalence and population structure of the parasite in a particular area. 
The seroprevalence of T. gondii in cats worldwide is estimated to be 30-40%.   
In addition to being a definitive host of T. gondii, domestic cats are susceptible to clinical disease 
due to T.gondii. Although uncommon, feline toxoplasmosis occurs in immunosuppressed cats, 
congenitally infected kittens and occasionally in otherwise clinically healthy individuals. Little is 
known about whether parasite genotype is associated with severity of disease in naturally 
occurring toxoplasmosis of domestic cats.   
The first aim of this research was to expand knowledge of feline T. gondii infections in Australia 
by determining the seroprevalence of T. gondii in owned Australian cats and identifying risk-
factors for infection. The second aim was to determine whether the genotype of T. gondii is a 
significant determinant of whether cats develop clinical toxoplasmosis.  
To estimate seroprevalence of T. gondii in Australian owned cats, Toxoplasma specific IgG 
ELISAs were performed on sera from 425 owned domestic Australian cats. A multivariate 
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analysis of the results from a questionnaire given to the owners was used to evaluate lifestyle 
factors which could contribute to increased likelihood of infection. 
Of the 425 cats tested in this study 38% (n=162) were seropositive. The prevalence in different 
geographic regions ranged from 16-71%.  Cats fed raw beef or raw kangaroo in their diet or cats 
that hunted rodents were significantly more likely to be seropositive  
To identify the genotypes associated with latent and active infections in Australian cats, tissue 
samples were collected from cats undergoing routine post mortem examination at the 
University Veterinary Teaching Hospital (n=28). Serology to detect T. gondii specific IgG was 
performed after collection of heart blood from cats of unknown T. gondii serostatus. Cases were 
chosen based on the likelihood of a cat being exposed to the parasite. Results of a PCR 
targeting the B1 gene to detect T. gondii DNA were positive in tissue samples from 11 of 17 
(65%) seropositive cats tested including four with clinical toxoplasmosis and seven with 
latent infections, as determined by serology, histologic findings and immunohistochemistry. 
Three of the four cats with clinical toxoplasmosis were immunosuppressed.  T. gondii type II 
(ToxoDB genotype #3) was determined in four cats with clinical toxoplasmosis and three cats 
with latent toxoplasmosis using PCR-RFLP at 12 loci (SAG1, 5’SAG2 and 3’SAG2, altSAG2, 
SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1 and Apico) and direct sequencing of the multi-
copy B1 gene. Novel T. gondii B1 gene polymorphisms were detected in two strains (at 
nucleotide posititions 233, 366 and 595) and a B1 gene polymorphism unique to Australia 
was identified in another (guanine/adenine at nucleotide position 378). One cat was co-
infected with two or more type-II like strains at 3’SAG2. The results of this study suggest that 
the infecting T. gondii genotype is not a determinant of clinical disease in cats naturally 
infected with T. gondii and type II strains are the most prevalent in Australia. 
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The ToxoDB#3 genotype has been previously identified in Australian hosts. Given the high 
prevalence in the present study, it appears that this genotype may be endemic to Australian 
hosts and this discovery warrants further investigation of a larger sample set using high 
resolution techniques such as those presented in this thesis to confirm this.  
Naturally infected cats with active and latent infection were both infected with the same strain, 
indicating the infecting strain is not the major determinant of disease progression and that 
other host factors may be of greater importance. 
Throughout this program of research, epidemiological aspects of feline T. gondii infections in 
Australia were elucidated further. Key findings include a seroprevalence of 38% among owned 
Australian cats, the identification of a cat which was  infected with more than one strain of T. 
gondii, the discovery that infections with the same ToxoDB#3 genotype can cause both clinical 
and latent infection in cats and the confirmation of diversity at the B1 locus in felines, which has 
been previously found in Australian wildlife species. This is the first survey of feline infections 
in owned Australian cats to evaluate lifestyle factors which contribute to the likelihood of 
exposure and it is also the first study to genetically characterise infecting strains in cats with 
clinical toxoplasmosis. Further studies are needed to fully understand the population structure 
and also the prevalence of T. gondii in Australia as current data is lacking in other domestic and 
wildlife species.  
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Chapter 1. Introduction  
Chapter one of this thesis introduces the parasite, describes the life cycle of T. gondii 
and reviews the literature on the worldwide population structure of the parasite and 
current knowledge about the relationship between strain and virulence in T. gondii 
infections. The second half of this chapter focuses on T. gondii infections in cats and 
reviews data on T. gondii in Australia. This chapter concludes with the aims of the 
studies that make up this thesis.  
1.1 Toxoplasma gondii  
T. gondii is an obligate intracellular coccidian parasite that causes toxoplasmosis. It is 
one of the most prevalent parasites and can infect almost any nucleated cell in all 
species of warm-blooded animals (Beazley and Egerman, 1998). Members of the felidae 
family are the definitive hosts as sexual reproduction of the parasite can only occur in 
the intestinal epithelium of felids. All other hosts are intermediate hosts, in which T. 
gondii can undergo asexual division (Beazley and Egerman, 1998).  
T. gondii is responsible for the disease toxoplasmosis. The course of disease and clinical 
presentation of toxoplasmosis in each species, and even in each individual,  vary greatly 
depending on genetic background, immunological status, inoculum size, and virulence 
of the strain (Beazley and Egerman, 1998; Robert-Gangneux and Darde, 2012).  
1.2 Discovery of the parasite and history clinical observations  
Toxoplasma gondii was discovered accidently in 1908 by Charles Nicolle who was 
studying Leishmania in the native rodent Ctenodactylus gundi in North Africa (Innes, 
2010). The parasite was named for the arc-like appearance of the tachyzoites and 
bradyzoites that Nicolle found.  
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The first conclusive case of T. gondii causing human disease was identified by Wolf and 
colleagues (1939), in an infant girl who had convulsive seizures three days after birth. 
She died at one month old and a post mortem examination found T. gondii in lesions of 
encephalomyelitis and retinitis. Tissue samples fed to rabbits and mice caused 
encephalitis in both species.  
The veterinary importance of T. gondii was first indicated when the first canine 
toxoplasmosis case was diagnosed in 1910 (Dubey, 2008; Mello, 1910). Subsequently 
the parasite was found to be associated with disease in several other species, most 
notably being associated with abortions in sheep in New Zealand (Hartley and Marshall, 
1957). 
 
1.3 Life cycle of the parasite 
The life cycle of Toxoplasma gondii is summarised in figure 1.1 and discussed below.  
 
 
 
 
 
 
 
 
 
Tissue cyst in intermediate host 
ingested by definitive host (cat) 
Unsporulated oocysts passed in faeces contaminate 
the environment and sporulate after one to five days 
Oocysts in water or plant 
matter are ingested by 
intermediate hosts 
Tissue cysts in intermediate hosts 
consumed by carnivores  
Tachyzoites in infected mother 
travel across the placenta and 
infect fetus  
Fig1.1 The life cycle of T. gondii  
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1.3.1 Sexual phase 
The sexual stage (also referred to as the enteroepithelial stage) of the parasite's life 
cycle occurs within the intestines and can be completed within 3-10 days in 97% of 
naïve cats (Dubey, 1996). Ingested tissue cysts are the most common infectious stage of 
the T. gondii life cycle that will cause cats to excrete oocysts (Dubey, 1996; Dubey and 
Frenkel, 1976). After ingestion, enzymes break down cyst walls and bradyzoites are 
released into the stomach and small intestine (Jacobs et al., 1960). Following digestion 
of the cyst wall, bradyzoites penetrate the intestinal wall and begin development of 
several generations of T. gondii and five pre-determined asexual stages (A-E) develop 
(Dubey and Frenkel, 1972). There are several generations within each asexual stage; 
after a number of generations male and female gamonts are formed and fertilisation 
occurs to form an oocyst (Dubey and Frenkel, 1972).  
Oocysts are one of three infectious stages in the life cycle of T. gondii. Once they have 
been formed, they are passed (unsporulated and, therefore, non-infectious) in faeces 
(Fig 1.1). Exposure to air and moisture for one to five days results in sporulation. Once 
sporulated, the oocyst contains two sporocysts, which contain four sporozoites. The 
sporozoites are the infectious agent. They are extremely resistant to environmental 
pressure (Hutchison, 1965).  
 
1.3.2 Asexual phase 
The stage of the life cycle, which occurs in both definitive and intermediate hosts, 
referred to as the extraintestinal cycle, is asexual (Fig 1.1). After the digestion of oocysts 
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or tissue cysts, sporozoites or bradyzoites (in the case of tissue cyst ingestion) excyst 
and penetrate intestinal epithelial cells. The sporozoites and bradyzoites then divide 
asexually in two via a process called endodyogeny to become tachyzoites. Tachyzoites 
are a rapidly multiplying, invasive stage of T. gondii, which can multiply in almost any 
cell and are carried around in the blood stream to infect other tissues. Tachyzoites enter 
cells via active penetration and are protected from host immune action by a self-made 
parasitophosphorous vacuole (Dobrowolski and Sibley, 1996). Following penetration of 
the intestinal epithelium, tachyzoites continue to multiply until the cell ruptures, after 
which tachyzoites will travel through the blood stream to infect new cells. The presence 
of tachyzoites evokes a very strong host interferon gamma (IFN) cell mediated immune 
response which eventually controls the tachyzoite stage, but not without causing 
significant damage to the host (Montoya and Liesenfeld, 2004). The amount of 
inflammation required to control the tachyzoite stage causes cell death and damage, 
which can manifest as visible clinical signs (Montoya and Liesenfeld, 2004). This strong 
immune response forces tachyzoites to encyst.  
Once encysted, tachyzoites become bradyzoites, which are morphologically similar, but 
functionally different. Tissue cysts grow intracellularly and the bradyzoites within 
multiply at a much slower rate than tachyzoites. Cysts are most commonly formed in 
the central nervous system, muscles and visceral organs. It is these cysts that facilitate 
T. gondii's ability to reinfect an individual as cysts persist for the life of the host and are 
not affected by the host immune action against tachyzoites (Saeij et al., 2005). 
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1.4 Transmission  
It was not until the invention of the Sabin-Feldman dye test that the life cycle and 
transmission routes of T. gondii were able to be explored (Weiss and Dubey, 2009). The 
invention of this sensitive and specific test allowed researchers to investigate the 
epidemiological characteristics of the parasite in humans and several other animals.  
Subsequently, more T. gondii infections were diagnosed than could possibly be caused 
by congenital transmission alone, which was assumed to be the main route of infection, 
specifically in sheep (Hartley and Marshall, 1957; Innes, 2010). This prompted further 
investigations into the possible transmission routes of T. gondii. 
It is now known that the wide spread distribution of T. gondii can be attributed to the 
many mechanisms of transmission and that T. gondii can be transmitted both 
horizontally and vertically. Horizontal transmission can occur via ingestion of tissue 
cysts from intermediate hosts, ingestion of oocysts in water, soil or vegetation 
contaminated by infected feline faeces and via organ transplants and blood transfusions 
(Fig1.1) (Beazley and Egerman, 1998; Montoya and Liesenfeld, 2004). Vertical 
transmission occurs when tachyzoites are transmitted across the placenta after a naïve 
female is infected during the gestational period. Susceptibility to both horizontal and 
vertical transmission routes have been reported in a variety of species including dogs, 
cats, grey kangaroos and humans (Al-Qassab et al., 2009; Parameswaran et al., 2009b; 
Powell and Lappin, 2001; Wilson et al., 1980). 
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1.4.1 Horizontal transmission and infectious agents 
Carnivorism and bradyzoites  
In 1960, Jacobs and colleagues discovered that the parasitophosphorous vacuole of T. 
gondii could be broken down via proteolytic enzymes in the gut and that bradyzoites 
could survive within the acidic gut environment. This discovery revealed that 
bradyzoites could survive long enough in the gut to infect a new host once a tissue cyst 
has been ingested (Jacobs et al., 1960). These findings were supported by 
epidemiological research, which suggested that areas where the consumption of 
undercooked or rare meat was common, had a higher prevalence of toxoplasmosis 
(Innes, 2010).  
Infection after the consumption of tissue cysts from immediate hosts occurs when 
proteolytic enzymes breakdown the parasitophosphorous vacuole surrounding the 
tissue cyst. This releases bradyzoites, which quickly differentiate into tachyzoites and 
penetrate the intestinal epithelium and begin asexually reproducing (Fig 1.1). 
Infection due to carnivorism is considered to make up a significant portion of cases and 
it is this transmission route, which allows the parasite diversity to be perpetuated 
sexually in feline hosts (Herrmann et al., 2012). Bradyzoites can be found within tissue 
cysts in several species, which are used for human and pet consumption including 
sheep, pigs, chickens and beef (Dubey et al., 2005b; Opsteegh et al., 2011; Wang et al., 
2013). Bradyzoites are also found in game meat (Dubey et al., 2013; Mancianti et al., 
2013; Pan et al., 2012; Parameswaran et al., 2010).  
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Several human toxoplasmosis outbreaks have been traced back to the consumption of 
contaminated meat. In Korea, two outbreaks of acute toxoplasmosis were attributed to 
the consumption of undercooked pork, and in America and French Guiana outbreaks of 
acute toxoplasmosis were attributed to consumption of undercooked game meat 
(Carme et al., 2002; Choi et al., 1997; Ross et al., 2001). 
Oocysts  
The discovery of T. gondii transmission through undercooked meat accounted for 
several cases of toxoplasmosis, which could not be explained by congenital 
transmission. However, it did not account for similar exposure rates in vegetarians and 
people whose diet included meat. This disparity called for further investigation into a 
potential third route of transmission (Rawal,1959). The third route was discovered by 
William Hutchison who found a new environmentally resistant form of the parasite in 
the faeces of cats, which he associated with the nematode parasite Toxocara cati 
(Hutchison, 1965). The Isospora-like oocysts were found to be extremely 
environmentally resistant, and remained infectious after 12 months in water 
(Hutchison, 1965). Further experiments established that T. gondii could be transmitted 
independently of T. cati ova as the T. gondii oocysts could be found in worm-free cat 
faeces (Dubey, 1968). 
Once the oocyst was discovered as an independent infectious agent it became clear that 
cats had a crucial role in the transmission of T. gondii. The sexual life cycle of T. gondii 
within feline intestinal tracts was discovered some five years later and led to T. gondii 
being classified as a coccidian parasite (Hutchison, 1969; Hutchison et al., 1970).  
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Transmission by oocysts occurs when a host ingests vegetation or water, which has 
been contaminated with feline faeces containing oocysts. It is one of the most effective 
routes of transmission for T. gondii due to extreme environmental resistance of oocysts 
(Fig 1). Depending on environmental conditions, sporulated oocysts can remain 
infectious for up to one year after shedding. Oocysts can survive water submersion, soil 
submersion for extended periods of time, and are resistant to detergents (Frenkel et al., 
1975; Wainwright et al., 2007). 
The development of an assay to differentiate oocyst infections from other infection 
types by detecting antibodies for sporozoites revealed the relative importance of 
environmental contamination in the transmission of T. gondii. In some instances, 78% of 
mothers who gave birth to congenitally infected children had acquired infections from 
oocyst ingestion (Yan et al., 2012). 
Contamination of vegetation and water by oocysts is the main transmission route for 
terrestrial herbivores, which can subsequently infect carnivores through bradyzoite 
consumption. This is significant because it can perpetuate the cycle between cats and 
wildlife and subsequently perpetuate the sexual phase of T. gondii life cycle. Marine 
mammals can also be infected via oocyst contamination of seawater and molluscs 
(Miller et al., 2004; Roe et al., 2013).  
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1.4.2 Vertical transmission  
Congenital transmission 
Congenital transmission of T. gondii is a result of transplacental transmission of 
tachyzoites (Abbasi et al., 2003) (Fig 1.1). This route of transmission occurs when a 
naïve woman is infected during the first two months of gestation. Women infected 
before this are considered immune and, therefore, unlikely to transmit infection. 
However, there have been reports of immunocompromised patients transmitting 
infections which were acquired earlier than one to two months prior to gestation 
(Garcia, 1968; Gavinet et al., 1997; Vogel et al., 1996). Infection severity and possibility 
of foetal infection are inversely related; infections in the first trimester are the most 
severe but least likely to happen (Desmonts and Couvreur, 1974; Sever et al., 1988).  
 
1.5 Population structure of T. gondii  
 
The first studies to use methods other than virulence in mouse bioassays to analyse the 
population structure of T. gondii involved isoenzymes and a few RFLP (restriction 
fragment length polymorphism) markers (Darde et al., 1992; Darde et al., 1988; Sibley 
and Boothroyd, 1992).  Initially, these techniques grouped strains that were virulent to 
mice together, while non-virulent strains seemed to be more diverse (Sibley and 
Boothroyd, 1992). These results were confirmed by Howe and Sibley (1995) using RFLP 
at other loci and the techniques were expanded to test more isolates from different 
continents and a number of different host species. Of the isolates tested 84% could be 
categorised into three clonal types which suggested an epidemic population where 
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sexual recombination of T. gondii was a rare event (Howe and Sibley, 1995). However, 
the isolates tested were mostly from humans or domestic animals in only a few regions. 
As further studies expanded on the markers used and the locations sampled, it was 
revealed that the T. gondii population is not entirely clonal. In South America, higher 
resolution techniques with better discriminatory markers and microsatellites found 
genotypes in French Guiana that were distinct from those found previously and these 
populations had more diversity between strains as well (Ajzenberg et al., 2004; 
Lehmann et al., 2004). Later, Su and colleagues (2006) confirmed that clonality was not 
the rule by using standardised RFLP across nine unlinked genomic markers to genotype 
Brazilian samples and to genotype previously typed strains with more loci as most 
previous techniques only typed at a single SAG2 locus. 
As more genetic data was generated from a broader geographic range and different 
hosts, distinct subgroups were found in South America, Europe, Africa, Asia, and Central 
America (Lehmann et al., 2006). Su and colleagues (2012) later used a combination of 
RFLP, microsatellite and sequence based markers (based on introns in housekeeping 
genes) to cluster genotypes into major groups of related strains. The 956 isolates from 
diverse geographic locations could be grouped into six clades, which were likely formed 
because of the interbreeding of a small number of founding populations. Some of the 
clades showed related yet divergent genotypes suggesting a mutational drift and/or 
recombination while others were made up of one genotype. This study confirmed that 
in Northern America and Europe, T. gondii exhibits a highly clonal population with three 
predominant genetic lineages: Type I, Type II, Type III and a less common haplogroup 
12. South America exhibited a high level of diversity with a mixture of diverse 
genotypes and clonal genotypes. (Su et al., 2003; Su et al., 2012).  
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More recently, Shwab and colleagues (2014) gathered information on all of the isolates 
that had been typed using the 10-loci RFLP technique designed by Su and colleagues 
(2006; 2010) and generated a report on the distribution and abundance of T. gondii 
genotypes throughout the world. The 1457 samples in this report were typed into 189 
genotypes and again confirmed the findings of previous authors that T. gondii exhibits a 
clonal population structure in Northern America and Europe, and that Southern 
America exhibits an epidemic population comprised of hundreds of different genotypes 
with no clear dominant strains. 
The ever-increasing number of distinct genotypes has created a need for a new 
nomenclature.  As the PCR-RFLP technique developed by Su and colleagues (2006, 
2010) is favoured for its high resolution, ease of use and cost effectiveness, a database 
called ToxoDB has been created whereby users can upload the sequences of isolates 
types using multi-locus RFLP techniques (Gajria et al., 2008). Isolates in this database 
are typed using 10 markers: SAG1, SAG 2 (3/5’-SAG2 and alt.SAG2), SAG3, BTUB, GRA6, 
c22-8, c29-2, L358, PK1 and Apico (Su et al., 2010; Su et al., 2006). The 10-marker 
technique is sometimes described as an 11- marker technique as the 3/5’ SAG 2 and 
alt.SAG2 markers can be considered to be two separate markers. With the addition of 
the Apico allele, this technique is able to differentiate between clonal Type II and Type II 
variant genotypes. In Type II clonal isolates the Apico allele is a Type II allele. However, 
the Type II variant genotype has a Type I allele at this locus. The most common 
genotypes and their corresponding ToxoDB genotype are presented in Table 1.1.  
Other systems of genotype designations are described by Weiss and Kim (2011). In this 
thesis, the ToxoDB genotype system is used. 
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To date, the most frequently identified strains of T. gondii found worldwide include 
Type III (ToxoDB#2), Type II variant (ToxoDB#3), Type II clonal (ToxoDB#1), Type 12 
(ToxoDB#5), Type BrI (ToxoDB#6), ToxoDB #7, Type BrIII (ToxoDB#8) and Type I 
(ToxoDB #10) (Shwab et al., 2014). The dominant strains on each continent vary; Type 
II variants and Type III were dominant in Africa, Chinese 1 and Type I in Asia, Type I, 
Type II and Type III in Europe, Type I, Type II, Type III and Type 12 were dominant in 
Northern America, while no dominant strains were identified in South America.   
The clonal genotypes I, II, and III are responsible for most infections in humans and 
domestic animals in North America and Europe (Grigg and Boothroyd, 2001; Lehmann 
et al., 2006; Lindstrom et al., 2008). It is hypothesised that these three dominant strains 
are a result of a bottleneck event in which a single genetic cross occurred followed by 
radiation (Su et al., 2003). In South America, among wildlife in the United States and in 
some parts of Africa and Asia the rich diversity of atypical genotypes likely result from 
sexual recombination in the definitive host (Ajzenberg et al., 2004; Lehmann et al., 
2006; Miller et al., 2004). Some of these atypical strains are clearly related to the three 
dominant strains, with mixtures of archetypal alleles and non-archetypal 
polymorphisms while others, referred to as “exotic” strains, have novel alleles at each 
locus (Khan et al., 2007). 
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Conventional genotype 
designation 
ToxoDB PCR RFLP genotypes 
Type I #10  
Type II (clonal) #1 
Type II (variant) #3 
Type III #2 
Type 12 (atypical, exotic) #4 
Type 12 (atypical, exotic, types A 
and X) 
#5 
Type BrI and Africa I #6 
Type BrII #11 
Type BrIII  #8 
Type BrIV  #17 
Chinese 1 #9 
Table 1.1 The traditional name of common T. gondii genotypes and their corresponding 
ToxoDB genotype designation (table appropriated from Shwab et al., (2014)). 
1.5.1 Strains and virulence 
Different strains of T. gondii have characteristics that affect their virulence in different 
hosts. For example, sea otters, harbour seals, and sea lions are prone to developing 
encephalitis when infected with an atypical strain of Type X, while infections with this 
strain in terrestrial wildlife are usually not associated with clinical signs of disease 
(Dubey et al., 2011; Miller et al., 2004). Recent studies have focussed on the genetic 
variability of T. gondii and the effect of strain type on virulence. Experimental virulence 
is determined using a mouse model. It is often stated that Type I is the most virulent in 
mice; infections with Type II or Type III strains are usually subclinical, and other non-
clonal strains are more likely to have increased virulence if they have a majority of Type 
I alleles (Ajzenberg et al., 2004; Darde, 2004; Luder et al., 1998; Mercier et al., 2010; 
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Saeij et al., 2005; Su et al., 2002b). Factors thought to affect virulence include variation 
in migration abilities, growth rate and ability to manipulate the host immune system. 
The ability to migrate effectively across barriers such as the gut epithelium, blood-brain 
barrier or placenta, is essential for infection and dissemination of T. gondii. Certain 
subpopulations of Type I strains have superior migration abilities when compared to 
Type II and Type II strains. This enhanced ability is attributed to a long distance 
migration (LDM) phenotype found only in Type I parasites (Barragan and Sibley, 2002). 
Improved migration abilities are an effective and important component of new and 
reactivated infections as better migration results in better dissemination to multiple 
systems, which can enhance pathogenesis.  
The ability of T. gondii to manipulate host immune responses makes it extremely 
successful. The parasite can use antigen-presenting cells as effective Trojan horses, 
essentially evading the immune system via down regulation of surface molecules. T. 
gondii decreases MHC II up-regulation of murine bone marrow-derived macrophages by 
50%, although MHC I regulation is not affected (Luder et al., 1998).   
Toxoplasma gondii can also transiently block the translocation of Nuclear Factor-kappa 
Beta (NF-κβ) in mice and human fibroblasts, thereby inhibiting the transcription of pro-
inflammatory genes and preventing the production of cytokines after cell invasion 
(Butcher et al., 2001). Differences in strains with regards to this ability have been 
reported. For example, Type I and Type III do not induce NF-kB translocation in mice 
where Type II does (Dobbin et al., 2002). 
The growth rate of a parasite is also a significant factor which can affect virulence. A 
faster growth rate results in an increased parasite load and an overstimulation of the 
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immune system, which results in increased inflammation and necrosis manifesting in 
severe clinical signs. The most virulent strain in mice Type I, is also the strain that 
induces a parasite load 1000 times greater than the less virulent Type II strain (Hill et 
al., 2012). 
. The inoculum size and infectious phase of the parasite, the genetic background and 
immunological status of the host are also significant virulence factors of T. gondii. 
There is, however, evidence to indicate that strains can have an important impact on the 
clinical outcome of an infection, specifically in immunocompetent hosts who normally 
develop a subclinical infection when infected with clonal strains. Moreover, association 
between atypical strains and severe clinical manifestations have been reported in 
human infections (De Salvador-Guillouet et al., 2006; Ferreira et al., 2011; Grigg et al., 
2001; Stajner et al., 2013). For example, T. gondii strains isolated and genotyped from 
three of 16 immunocompetent human patients with severe primary toxoplasmosis in 
French Guiana were all atypical strains (Carme et al., 2002).  The severity of 
toxoplasmosis is lower in regions where clonal strains are common, such as Western 
Europe, and Northern America (Howe and Sibley, 1995) and is comparatively high in 
regions where more atypical strains circulate, such as South America (Carme et al., 
2002; Khan et al., 2006; Vallochi et al., 2005). In France, Type II strains are strongly 
associated with congenital toxoplasmosis and its various manifestations (Ajzenberg et 
al., 2002). 
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1.6 Detection methods  
Toxoplasma gondii can be detected in biological samples using direct or indirect 
methods. Indirect serological methods used on live subjects are particularly useful in 
immunocompetent patients to indicate exposure; whereas direct methods are more 
definitive but require tissue or fluid samples. Because this thesis will focus on both 
direct and indirect molecular methods in both clinical and latent infections- a summary 
of both types of techniques is presented below. 
 
1.6.1 Indirect  
Once an animal is infected with T. gondii, tissue cysts persist for life. Infection stimulates 
a long-term humoral immune response, which is detectable using serological methods. 
Indirect detection methods use serological techniques such as the Sabin-Feldman dye 
test, indirect fluorescence antibody test (IFAT), Immunoglobulin G (IgG) 
/Immunoglobulin M (IgM) Enzyme Linked Immunosorbent Assay (ELISA), IgG avidity 
and agglutination tests. A combination of a number of these tests can be used depending 
on the information required (Montoya, 2002). 
These tests utilize the fact that T. gondii stimulates a strong and persistent humoral 
response. Experimental infection of cats with T. gondii induces IgM production one to 
two weeks post-infection and IgG levels peak two months after infection and are 
detectable for life (Lappin et al., 1991). By measuring the levels of these two T. gondii 
specific antibodies, exposure to the parasite can be confirmed.  
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 1.6.2 Direct detection methods  
Direct detection methods confirm the presence of T. gondii in a biological sample by 
detecting parasitic DNA or isolating parasites. Examples of such techniques include 
bioassays (most commonly in mice or cell cultures), histological methods, hybridization, 
and amplification of characteristic genes by PCR (Montoya and Liesenfeld, 2004). 
These methods can be divided two types: molecular identification and isolation of the 
parasite. Isolation of the parasite can be performed using bioassays and histological 
methods. Bioassays involve either inoculating or feeding potentially infected tissue to a 
test species- usually mice or T. gondii naïve cats. 
When a mouse bioassay is performed to determine whether a sample is T. gondii 
positive, SPF mice are fed the sample or given an intraperitoneal injection of the sample. 
serology is carried out on mice serum and microscopic analysis of brain tissue for cysts 
is performed. In some cases, DNA is extracted from infected mouse tissues and PCR is 
performed (Dubey et al., 2003). If T. gondii antibodies are found, parasites or parasitic 
DNA are found in microscopic or molecular analysis of tissues or blood from the SPF 
mice then the presence of T. gondii in the sample is confirmed. 
When naïve cats are used in a bioassay, the sample is fed to uninfected SPF cats and 
faeces are examined for oocyst shedding. Cats are also tested for seroconversion 
(Dubey, 1968). If oocysts are detected in faeces, if the cat becomes seropositive, or if 
parasites are detected on necropsy then the presence of T. gondii in a sample is 
confirmed. Not all cats will seroconvert immediately, or even within the study period, 
therefore seropositivity in cats should not be used as the sole indicator of exposure.  
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 Molecular detection of T. gondii involves the amplification of characteristic genes using 
PCR to indicate the presence of T. gondii in a sample.   
PCR was first used to detect T. gondii DNA by Burg and colleagues (1989). Burg and 
colleagues (1989) amplified the 35-fold-repetitive gene B1 and were able to detect as 
few as 10 parasites in 100 000 human leukocytes. Since then other characteristic 
markers have been used to indicate the presence of T. gondii in a biological sample and 
to characterize the genotype of the strain. The most common markers used are 
repetitive sequences B1 and a 529 bp sequence. Several other single copy genes such as 
the surface antigens SAG1, SAG 2, SAG4, SAG3, GRA4 and GR6 have been used as PCR 
targets for T. gondii. 
The markers used depend largely on the aims of the analysis. If only identification is 
required, multiple copy markers are preferred due to increased sensitivity. However, if 
high-resolution fingerprinting or genetic characterization of the isolate is required, then 
more specific multi-locus markers or microsatellite markers are used.  
A large number of studies use a standardized RFLP protocol designed by Su et al (2010) 
however, there are other methods such as microsatellite analysis that are gaining 
increasing popularity as these markers can be used to determine sources of outbreaks. 
Most studies that use this technique utilize 15 microsatellite markers as described by 
Ajzenberg and colleagues (2010). 
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2. Toxoplasmosis 
2.1 Prevalence and population structure in cats 
T. gondii is prevalent in cat populations throughout the world. Infection is usually 
subclinical. Feral and stray cats have a higher seroprevalence than domestic cats, 
especially those domiciled indoors (Nutter et al., 2004; Wu et al., 2011).  
Recent studies have found a seroprevalence of 85.4% of feral cats sampled in Ethiopia 
(Tiao et al., 2013), 44.2% in Portugal (Waap et al., 2012), 21.3-85.4% in China (Tiao et 
al., 2013; Wu et al., 2011), 95.5%-97.4% in Egypt (Al-Kappany et al., 2011; Al-Kappany 
et al., 2010b) and 17.5% in Korea (Lee et al., 2011). While these figures demonstrate a 
generally high and varied prevalence worldwide, factors that affect seroprevalence are 
incompletely understood. Regional outdoor cat density, incidence of T. gondii infection 
in intermediate hosts, mean annual precipitation and climate have been suggested to 
play a role in feline T. gondii seroprevalence (Afonso et al., 2010; Masaaki et al., 2015). 
 
A number of genotypes of T. gondii have been identified from latently infected cats with 
regional specific distribution. ToxoDB#9 is the most prevalent genotype found in the 
tissues of Chinese stray cats (80% of 35 cats sampled) (Qian et al., 2012; Tian  et al., 
2014; Yang et al., 2015) whereas Type II clonal genotypes (ToxoDB#1) are the most 
common genotypes found in European stray and household cats with 82% of 151 cats 
tissues sampled typed as Type II (Can et al., 2014; Montoya et al., 2008; Vilares et al., 
2014).  
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2.2 Disease in felines 
Clinical feline toxoplasmosis was first reported in 1942 from a four-month old cat in 
Middletown, New York, USA (Dubey, 2008). The occurrence of disease in cats has been 
well documented worldwide since this discovery (Dubey and Carpenter, 1993; 
Hartmann et al., 2013; Lappin et al., 1989). Although clinical disease is uncommon, 
severe systemic feline toxoplasmosis was reported in 3% of feline cases submitted for 
necropsy over a two or three year period in Europe (Henriksen et al., 1994; Jokelainen 
et al., 2012). Figures such as these indicate that toxoplasmosis is a significant cause of 
feline mortality. 
It has been proposed that strain type, immune status, age of the individual, and 
concurrent infections can play a role in determining the severity of an infection in feline 
hosts (Dubey and Powell, 2013).  The relative importance of each of these factors in 
determining the severity of feline toxoplasmosis remains to be determined. 
Cats that are most severely affected by toxoplasmosis are those that acquire 
toxoplasmosis congenitally or are immunocompromised. The central nervous system 
(CNS), muscles, pancreas, lungs and eyes are areas commonly affected in cats, and 
widespread systemic disease can occur (Davidson et al., 1993b; Hartmann et al., 2013; 
Last et al., 2004; Nagel et al., 2013; Spycher et al., 2011, Dubey and Carpenter 1993).  
Infections can be primary or recrudescent. Recrudescent infections occur when 
immunosuppression results in cyst rupture, bradyzoite dissemination and 
transformation into rapidly replicating tachyzoites. Common clinical signs in cats 
include but are not limited to neurological signs (eg seizures, ataxia), muscular 
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hyperaesthesia, dyspnoea, uveitis, icterus, diarrhoea, fever, lethargy, nasal secretions, 
anorexia and weight loss (Hartmann et al., 2013; Jokelainen et al., 2012).  
3. Toxoplasma gondii in Australia 
T. gondii is reportedly common in Australian wildlife and cats. Despite this, there is a 
surprising lack of recent information regarding the population structure of T. gondii in 
Australia and current rates of exposure in cats (Hartley and English, 2005; Hartley and 
Dubey, 1991; Jayamaha et al., 2012; Obendorf and Munday, 1983; Parameswaran et al., 
2009a; Sumner and Ackland, 1999).  
 
T. gondii seroprevalence rates in Australian marsupials range from 1.2% in Tasmanian 
Pademelons (Jakob-Hoff and Dunsmore, 1983) to 26.1% in wombats (Hartley and 
English 2005). While the seroprevalence of T. gondii indicates that toxoplasmosis is not 
invariably fatal, outbreaks of toxoplasmosis have been associated with declines and die-
offs of Australian marsupials such as the Eastern Barred Bandicoot (Perameles gunnii) 
and the Woylie (Bettongia penicillata) (Obendorf et al., 1996, Smith et al., 2008).  
There is a surprising amount of diversity among T. gondii genotypes in Australia, 
including variations and recombination of the three clonal genotypes prevalent Europe, 
North America and Africa and strains with atypical alleles (Pan et al., 2012; 
Parameswaran et al., 2010).  Of 46 Australian marsupials screened by multi-locus PCR 
DNA sequencing at polymorphic genes, 67% were PCR positive and infected with non-
archetypal/atypical strains (Parameswaran et al., 2010). 
A possible explanation for this diversity can be seen in data collected from macropods 
in Western Australia. All 16 asymptomatic marsupial macropods tested using PCR-DNA 
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sequencing for T. gondii were positive, thirteen of these macropods had parasite DNA in 
at least two organs and 45 distinct genotypes were detected.  Furthermore, 14 of the 16 
macropods were co-infected by multiple genetically distinct T. gondii genotypes 
(Parameswaran et al., 2010). If this data represents the general trend in Australian 
wildlife then it is highly likely that feral cats, which hunt native wildlife, are exposed to 
multiple genotypes and the likelihood of sexual recombination between these strains is 
increased.  
 
3. 1 T. gondii in Australian felines 
 
Clinical disease has been reported in a number of Australian cats, however, the identity 
of genotypes infecting Australian cats is unknown (Foster et al., 1998; Lister et al., 1999; 
Barrs et al., 2007; Beatty and Barrs, 2003; Lindsay et al., 2010). Only one isolate from a 
cat from Tasmania, of unknown infection state (latent infection or clinical disease), has 
been genotyped (ToxoDB#10, n=1: Refer to Table 1.1 (Parameswaran et al., 2010). 
There is also a lack of recent information on how often owned domestic cats are 
exposed to T. gondii in Australia. The majority of serological surveys were performed in 
stray and feral cats over 30 years ago (Coman et al., 1981; Gregory and Munday, 1976; 
Jakob-Hoff and Dunsmore, 1983; Milstein and Goldsmid, 1997; Sumner and Ackland, 
1999; Watson and McDonald, 1982). 
More recently, 85% of feral and stray cats sampled in Tasmania were found to be 
seropositive, indicating that these cats are regularly exposed to the parasite (Fancourt 
and Jackson, 2014).  
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Surveys conducted to determine frequency of oocyst shedding in Australian cats have 
found approximately 0.1-1.2% of refuge and domestic cats were shedding in one time 
period, a similar rate to that reported elsewhere in the world (Herrmann et al., 2010; 
Palmer et al., 2008). 
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4. Rationale for the project or aims of this thesis 
Currently, data on T. gondii prevalence and genotypes in Australia is sparse and 
knowledge about the impact of infecting genotype on disease outcome in feline 
toxoplasmosis is lacking. It is, therefore, important to expand the knowledge of 
genotypes present in definitive hosts and to determine prevalence in Australian cats.  
In light of the lack of information on the of T. gondii infections in cats, to the aims of the 
research presented in this thesis are to:  
 
1. Determine the seroprevalence of T. gondii in Australian domestic cats;  
2. Determine potential risk factors which increase the likelihood of exposure to T. 
gondii in domestic cats; 
3. Investigate the genotypes of Toxoplasma gondii present in Australian cats using 
high resolution techniques; 
4. Identify the genotypes of T. gondii found in cats that have clinically diagnosed 
toxoplasmosis. 
 
4.1 Thesis outline  
 
Chapter two describes the materials and methods used to conduct a 
seroepidemiological survey to estimate the seroprevalence of T. gondii infections in 
domestic owned cats in Australia and the results of this survey. In addition to estimating 
seroprevalence of T. gondii in owned Australian cats, this chapter also evaluates lifestyle 
factors, which may play a role in exposure to T. gondii in these cats.  
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Chapter three describes, in detail, the materials and methods used to collect samples 
from cats with active and latent toxoplasmosis and the genetic analysis which typed 
isolates found in these cats. 
 Chapter four contains a manuscript which has been submitted to Veterinary 
Parasitology and is under review. This manuscript describes cases of feline 
toxoplasmosis and also the results of the genetic characterisation of isolates of T. gondii 
found in cats with active and latent infections. This chapter directly compares 
genotypes found in active and latent feline infections in order to determine whether the 
severity of T. gondii infections in feline hosts is dictated by infecting strain. 
The final chapter concludes the thesis and discusses the main findings in accordance 
with the aim of the research. It also offers recommendations for further studies. 
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Chapter 2: Serological survey of T. gondii prevalence in owned Australian cats and 
risk factors for infection 
 
Toxoplasma gondii is a parasite of worldwide medical and veterinary importance. As the 
definitive host, cats are the only source of infectious oocysts which are shed in their 
faeces and are environmentally resilient.  During primary infection, one cat can shed 
between three and 810 million oocysts (Dabritz and Conrad, 2010). Oocyst shedding is 
transient and usually ceases when a cat has mounted a sufficient immune response to 
the parasite, as evidenced by seroconversion (Dubey, 1995a).  
In recent studies, the seroprevalence of T. gondii among owned domestic cats in 
Portugal, Tehran and the United States was between 30-40% (Haddadzadeh et al., 2006; 
Lopes et al., 2008; Vollaire et al., 2005). 
In Australia, there is little recent information regarding T. gondii seroprevalence among 
owned domestic cats, despite an estimated pet cat population of 3.3 million (Animal 
Health Alliance, 2013). The last recorded survey of T. gondii seroprevalence in owned 
Australian cats was performed in Melbourne over 15 years ago. At that time, 39% of pet 
cats were seropositive to T. gondii (Sumner and Ackland, 1999). Data on the 
seroprevalence of T. gondii among stray and feral cats on mainland Australia is also not 
current, with most studies being performed over 25 years ago. Previously, 20%- 39% of 
stray and feral cats in Victoria (Coman et al., 1981), and 30% feral cats and cats in 
shelters in Western Australia (Jakob-Hoff and Dunsmore, 1983) were seropositive. 
More recently, in Tasmania, seroprevalence among feral and stray cats was found to 
range from, 85-96% (Fancourt and Jackson, 2014).  
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Access to the outdoors, consumption of raw meat and hunting have previously been 
identified as risk factors associated with T. gondii exposure in domestic cats (Must et al., 
2015; Opsteegh et al., 2011). The relative impact of these factors on the prevalence of T. 
gondii in Australian cats has not been recently examined. However, in contrast to the 
United States, feeding of raw meat is common among pet owners and advocated over 
processed diets by some veterinarians (Lonsdale, 2001; Malik, 2015). Kangaroo meat is 
also a popular protein of choice to feed cats in Australia and 15.5 to 100% of kangaroos 
sampled have been found to be seropositive to or infected by T. gondii (Pan et al., 2012; 
Parameswaran et al., 2009a). 
The aims of this study were to determine the seroprevalence of T. gondii among owned 
Australian cats and to determine risk factors for T. gondii infection. 
2.1 Materials and methods 
 
2.1.1 Sample collection 
 
To determine T. gondii serological status, 1 mL of blood was collected from cats 
presenting to participating veterinary hospitals around Australia, with written informed 
consent of the owner and approval from the Animal Ethics Committee, University of 
Sydney April 9th 2015 (Protocol no. 2015/768). Samples were collected between 1st 
June 2015 and 30th September 2015. 
Following centrifugation and separation of the serum, all the samples were stored at -20 
°C until shipping on ice by courier. 
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2.1.2 Questionnaire  
 
A questionnaire for owners of participating cats was designed to collect data for risk 
factor analyses. Information collected included signalment (age, sex, health status and 
source), environment (outdoor access, proportion of time spent outdoors, urban or 
rural area and toilet options) and diet (diet composition, raw meat in diet, types of raw 
meat fed, hunting habits, and prey types).  The full questionnaire can be seen in 
Appendix 2.  
2.1.3 ELISA serology to determine the exposure status of each cat 
 
Samples were shipped for analysis to the Department of Clinical Sciences in the School 
of Veterinary Science, Colorado State University, Colorado, USA. 
An enzyme-linked immunosorbent assay (ELISA) to detect toxoplasma specific 
immunoglobulin IgG was performed. 
2.1.4 Plate preparation  
 
The ELISAs were performed using 96 well MicroELISA plates and a previously 
published method (Brown et al., 2005). Briefly, to sensitise the plates, an optimal 
dilution of T. gondii RH strain tachyzoites was determined by titration. This was 
pipetted into wells of a microELISA plate (Immulon I; SeraCare, Marylands, USA) in in 
100 µl 0.06 M carbonate buffer and the plate was incubated at 4°C overnight. Plates 
were sensitised in two batches. The optimal signal to noise ratio was calculated for each 
batch using log dilutions of known positive and negative controls.  A checkerboard 
titration was used to determine the optimal secondary antibody concentration. When 
the optimal signal to noise ratio was determined for both known positives and negatives 
42 
 
and for the secondary antibody, plates from each batch were used in an optimised assay 
including 20 known positive and 20 known negative sera of varying titres to determine 
assay cut-off levels for positive results. All positive and negative test results were 
confirmed with a commercially available latex agglutination kit (TOXOTEST-MTEiken, 
Tanabe USA, Inc., San Diego, California, USA).  
2.1.5 ELISA to determine the exposure status of each cat 
 
Samples 1-295 were run using plates from Batch 1 and samples 295-425 were run using 
plates from Batch 2.  
Plates and substrate (SureBlue TMB microwell peroxidase substrate; SeraCare, 
Marylands, USA) were removed from refrigeration (stored at 4°C) and allowed to 
equilibrate to room temperature. 
Plates were washed three times with 200µl PBS-Tween 20 (PBS-Tw 20- Appendix 3) 
using a plate washer. Standardised duplicate controls of known positive IgG pooled cat 
sera and known IgG negative, pooled cat sera (cats that had never been exposed to the 
parasite) were included on each plate. 
Negative and positive controls were assayed in quadruplicate and test sera were 
assayed in triplicate. Test samples and positive and negative controls were diluted 1:64 
in PBS-Tw. 20 Negative controls and test sera dilutions comprised of 14 µl of sera and 
882 µl of PBS-Tw 20. Positive controls consisted of 8 µl of pooled control sera and 504 
µl of PBS-Tw 20. Diluted samples were vortexed for 30 seconds and 100 µl of each 
diluted sample were added to the microELISA plate. The top row was left empty to act 
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Figure 2.1 A template for the plate setup used in this current study 
Samples 
Substrate wells  
+ve control - ve control 
PBS 
1 2 3 4 5      6      7       8   
 9     10   11    12    13   14    15    16 
17   18    19    20    21    22    23    24 
25 26 
as blank for absorbance readings. Plates were covered and incubated at 37 °C for 30 
minutes then washed with PBS Tw 20 as previously described.  
 
 
 
 
 
 
 
 
 
 
 
 
2.1.6 Secondary Antibody and dilutions 
 
Goat anti-cat Toxoplasma IgG (peroxidase labelled, heavy chain specific, SeraCare, 
Marylands, USA) was used as the secondary antibody to detect positive sera.  
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Secondary antibodies used in Batch 1 were diluted to a 1 in 1500 dilution and consisted 
of 6 µl of Goat Anti-cat toxoplasma IgG in 12 ml of PBS-Tw 20. Secondary IgG antibodies 
in Batch 2 were diluted 1 in 2000 and consisted of 8 µl Goat Anti-cat toxoplasma IgG in 
12 ml of PBS-Tw 20. Once diluted the secondary antibody solutions were mixed and 
added to rows 2 to 12 in the corresponding plate. Row 1 was left empty again. Plates 
were incubated at 37°C for 30 minutes. After incubation, the plates were washed three 
times with PBS-Tw as described previously.  
100 µl of the substrate (SureBlue TMB) was added to each row in the plate. Plates were 
incubated at room temperature for 10 minutes then 100 µl of 0.18M sulphuric acid 
(H2SO4) was added to each well to stop the initial reaction. Plates were read on a 
microELISA reader (Lab Systems Multiskan Ascent) using a 450nm wavelength.  
2.1.7 Calculations  
 
The mean absorbance for controls and each sample was calculated. The mean 
absorbance of each serum sample was compared to a standard curve developed from 
known negative and positive control sera and a titre was assigned.  Positive cut-off 
absorbance values were defined as being greater than the mean plus two standard 
deviations of the positive results from 20 SPF cats. Positive titres in these cats were 
confirmed using a commercially available latex agglutination kit as per manufacturer 
instructions (TOXOTEST-MTEiken, Tanabe USA, Inc., San Diego, California, USA). Titres 
>1:64 were considered positive and titres <1:64 were considered negative. The 
multiplication factor for Batch 1 and 2 was 2.3.  
A titre scale to determine the titre of each absorbance value on each plate was then 
created.  
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To create a titre scale, the average absorbance of the negative wells was multiplied by 
the multiplication factor to determine the cut off absorption for the 1:64 titre cut-off.  
The average absorbance for the positive control wells was calculated and placed at the 
corresponding titre.  
A linear absorbance scale was made using the following equation: 
Average negative control absorbance X multiplication factor  
number of titres between the negative cut off and the positive titre 
The value obtained from this equation was added to the 1:64 cut-off and then 
consecutively added thereafter to each titre bracket to give a value for each titre (an 
example of the calculations performed can be found in Appendix 4).  
The titre of each test sample was determined by calculating the average absorbance of 
the four values obtained and then this value was aligned with a titre bracket calculated 
as above.  
Statistical analysis 
 
Data analysis was conducted on binary data: IgG > 0 (1) vs IgG = 0 (0).  A logistic GLM 
was fitted to these binary data, with the same fixed and random effects structure as for 
the above model.  Similarly, a backwards elimination procedure was applied for model 
selection.  Both models were analysed using GenStat Release 17 (VSN International, 
Hemel Hempstead UK).  
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2.2 Results 
 
Serum samples were collected from 425 cats from 18 different veterinary hospitals 
around Australia (Figure 2.2). Of these, 38% (n=162) had positive ELISA results for the 
detection of Toxoplasma-specific IgG antibodies. The overall prevalence in different 
geographical regions ranged from 16 to 48%. The highest seroprevalence was reported 
in the Australian Capital territory and the lowest in Western Australia (WA). The 
variables tested and the corresponding seroprevalence associated with them are listed 
in Table 2.1.  
2.2.1 Statistical analysis  
 
The REML analysis showed that the frequency of feeding raw meat to a cat was the only 
significant variable left after backwards elimination of variables.  This showed a dose 
response with “no raw meat in diet” having the least predicted IgG value and “daily raw 
meat consumption” having the highest predictive value for a positive IgG titre.  The 
variables that were significant in the logistic model were eliminated from the linear 
model due to collinearity among the variables so that their effects could not be 
estimated.   These models are then complementary. 
 The general linear model found that meat related variables were a predictive value for 
a positive result.  Cats that had raw beef (P=0.0016) or raw kangaroo (P=0.005) in their 
diet were significantly more likely to have a positive result than those that did not have 
this type of meat in their diet. Cats that had raw lamb in their diet were significantly less 
likely to be seropositive (P= 0.004). There was no significant difference between 
seropositivity rates in male and female cats. When age was treated as a continuous 
variable the likelihood of positive serology increased with age (P < 0.001).  Cats that had 
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10 (n= 31) 
11-14  
 (n= 39) 
1-9 (n= 206) 
16 (n= 7) 
14-15(n= 89) 
17-18 (n=55) 
been observed by their owner to hunt rodents were significantly more likely (p=0.035) 
to be seropositive. Toilet options were not found to have a significant impact on the 
likelihood of a cat being seropositive (p=0.051) and the least significant difference test 
showed no significant difference between the options.  
State had a significant impact on the likelihood of seropositivity. Cats which were from 
Western Australia were significantly less likely to be seropositive that cats from any 
other state studied. Cats sourced from New South Wales were significantly more likely 
to be seropositive than those from Victoria. 
 
 
Fig 2.2 Distribution of veterinary hospitals that participated in the study and the number of 
sera collected from each site 
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Table 2.1 Toxoplasma gondii seroprevalence in Australian cats and lifestyle factors 
measured 
Variable   n 
n 
seropositive 
Seroprevalence 
(%) 
 p value 
Total   425 162 38   
Age       
 <12 months 32 2 6   
 >12 months 383 153 40   
Sex      1.423 
  male  208 78 38   
  Female 209 77 37   
Location           
  New South Wales 206 98 48   
  Queensland 69 25 36   
  Victoria 89 25 28   
  
Australian Capital 
Territory 
7 5 71   
  Western Australia 55 9 16   
Diet 
composition         
 0.799 
  No raw meat in diet 266 101 38   
  Raw meat 248 139 56   
Type of raw meat 
  
    
  Beef* 155 69 45  0.061 
  Chicken  150 68 45  0.298 
  Kangaroo* 99 48 48  0.005 
  Lamb  34 8 24  0.004 
  Pork  15 5 33  0.454 
  Other   11 3 27  0.353 
  Rabbit  7 1 14  0.511 
  Turkey  3 1 33   
Outdoor access        0.203 
  Yes    288 110 38   
  No  137 53 39   
Toilet options        0.051 
  Litter  225 82 36   
  Both 135 62 46   
  Outdoors 52 15 29   
Source          0.117 
  Breeder 126 47 37   
  Friend    11 5 45   
  Online/other  93 23 25   
  Pet shop  37 18 49   
  Stray  125 50 40   
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  Vet  3 1 33   
Boarder          0.805 
  Yes    164 73 45   
 
No  243 85 35   
Other cats      0.124 
 Yes   232 95 41   
 
No  182 67 37   
Hunter          0.614 
  Yes   225 94 42   
  No  176 58 33   
Prey type           
  Birds 72 32 44  0.740 
  Lizards 111 48 43  0.395 
  Rodents* 75 37 49  0.035 
  Insects 101 43 43  0.549 
  Slugs/snails 5 3 60  0.398 
  Frogs 2 0 0   
  Possums 2 2 100  0.948 
Note: * signifies as statistically significant result as determined by the GLM analysis 
2.3 Discussion  
 
This study is the first to sample multiple states in Australia for feline exposure to T. 
gondii as indicated by seropositivity. It is difficult to compare the figures reported in the 
present study to past figures as there are vast differences in techniques used, sample 
sizes, and geographical location sampled and prior to the present study, location 
variability was unknown.   The highest prevalence in the present study was recorded in 
the Australian Capital Territory however due to low numbers this was not found to be 
statistically significant. The seroprevalence in New South Wales is similar to that found 
in cats previously sampled in Sydney (Watson and McDonald, 1982) and was 
significantly higher than the other states sampled. This could be due differences in 
commercial diets available, the mean age of cats sampled in the state and the proportion 
of cats fed raw meat or cats who had the opportunity to hunt rodents.  
50 
 
The seroprevalence of cats in the present study is lower than that reported in feral and 
stray cats in Australia, with the exception of reports from Queensland where no feral 
and stray cats tested seropositive (Coman et al., 1981; Cook and Pope, 1959; Fancourt 
and Jackson, 2014; Jakob-Hoff and Dunsmore, 1983). Overall, higher rates 
seroprevalence among feral cats compared to pet cats, has been reported worldwide 
(Al-Kappany et al., 2011; Fancourt and Jackson, 2014; Tiao et al., 2013).  
The general linear model (GLM) found that inclusion of raw beef or kangaroo in a cat’s 
diet was predictive value for a positive result. There is currently no data on the 
prevalence of T. gondii infection in beef cattle in Australia. Serological surveys 
conducted in Brazil and Thailand found 17.7% and 25.7% of cattle tested, respectively, 
had been exposed to the parasite (Santos et al., 2013; Wiengcharoen et al., 2012). 
Limited bioassay studies in the US, in which naïve cats were fed raw beef, did not isolate 
viable T. gondii from cattle slaughtered for consumption (Dubey et al., 2005a). As a 
result of these findings, beef is often described as a “low risk” meat with regards to T. 
gondii transmission to humans (Dubey et al., 2005a).  However, despite this, similar to 
the present study, beef has been identified as a risk factor for T.  gondii infection in US 
citizens (Jones et al., 2009). 
 
Raw kangaroo meat in the diet was also a significant predictive variable for T. gondii 
exposure in cats in this study.  T. gondii DNA was detected in one of 10 kangaroo mince 
samples sourced from a supermarket in Perth, however, no other studies have made an 
attempt to expand on this finding (Parameswaran et al., 2010). Wild macropods 
sampled from the Perth metropolitan area had a seroprevalence of 15.5% 
(Parameswaran 2009b). By contrast, T. gondii DNA was detected in 16 of 16 wild 
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macropods sampled in Western Australia, indicating that Australian macropods have 
variable exposure to T. gondii (Pan et al., 2012; Parameswaran et al., 2009a). In other 
areas where kangaroos have not been surveyed, grass-grazing species such as wombats 
in New South Wales have a T. gondii seroprevalence of 26.1% (Hartley and English, 
2005). Further studies are warranted to determine the risk of T. gondii exposure after 
consumption of kangaroo meat in Australia. 
Raw beef was the most popular type of raw meat fed to cats in this study (n=154), 
followed by chicken (n=150), then kangaroo (n=99).  It is surprising that chicken was 
not identified as a significant risk factor for exposure to T. gondii in light of recent 
findings that 90% of free range chickens tested in Western Australia had serological 
evidence for exposure to T. gondii (Chumpolbanchorn et al., 2013). The reason for this 
could be that chicken sold for pet consumption is more commonly traditionally raised 
with no access to outdoor runs or exposure to oocysts in the environment.  Free-range 
chickens with outdoor access have been shown previously to have high seroprevalence 
rates (Millar et al., 2012). The identification of raw beef and kangaroo as risk factors for 
infection in owned domestic cats indicates that regardless of whether cats have outdoor 
access they may still be exposed to the parasite if they are fed these types of raw meat. 
This finding is concerning, as these two meat types were among the most common fed 
to cats in this study.  
Cats in this study that were observed by their owner to hunt and eat rodents were 
significantly more likely to be exposed to T. gondii (p=0.014).  There is little recent data 
regarding infection rates in rodent species in Australia, however, in 1959, 30% of native 
and feral rodent species in Queensland had serological evidence for infection, indicating 
that over 55 years ago rodents were commonly infected with T. gondii (Cook and Pope, 
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1959). The significant difference between seroprevalence rates in cats that were seen to 
consume rats and those that didn’t suggests that there may be high infection rates in 
rodents in Australia in comparison to other prey. In contrast to previous studies, there 
was no significant difference in seroprevalence rates between cats with or without 
outdoor access or between cats from single or multi-cat households. It is possible that 
rates of outdoor access reported by owners in this study were lower than actual 
outdoor exposure rates. In a recent survey of feline lifestyle factors conducted in 
Australia and New Zealand, 60% of cats that were reported to have no outdoor access 
had previously spent time outdoors (Johnston and McDonagh 2015). When this 
information was included, the proportion of cats that had outdoor exposure increased 
from 67% to 87% revealing a large difference between reported and actual outdoor 
exposure rates.   
Similar to outdoor access, the number of “multi-cat households” may be under reported 
in the present study as the survey did not account for previously owned cats that had 
passed away or neighbourhood cats that visit. Good litter hygiene, that is, daily litter 
changing could also explain why cats from multi-cat households in this study were not 
more likely to be seropositive that cats from single cat households, however, this was 
not assessed in the questionnaire.  
The results from the current study indicate that domestic, owned cats in Australia are 
commonly exposed to T. gondii and that raw meat, specifically beef and kangaroo and 
the predation of rodents are major risk factors for infection of owned Australian cats. 
Addressing these risk factors would decrease the likelihood of cats being exposed to T. 
gondii in Australia. For example, owners who feed their cats raw meat could freeze the 
meat for a minimum of 48 hours prior to feeding, which has been shown to destroy 
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tissue cysts (Djurkovic-Djakovic and Milenkovic, 2000; El-Nawawi et al., 2008; Gencay 
et al., 2013). Owners could reduce hunting opportunities by supervising or restricting 
outdoor access or investing in deterrents such as collar mounted pounce protectors or 
bells which have been shown to reduce mammal hunting (including rodents) by 55%, 
and mouse hunting by 63%, respectively (Calver et al., 2007; Gordon et al., 2010). 
Education with a focus on cat welfare would be an effective way to increase owner 
compliance as Australian cat owners have been shown to be more likely to implement 
change to cats lifestyles when welfare is advocated (Grayson et al., 2002).  
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Chapter 3- Methodology: Comparison of genotypes of Toxoplasma gondii in 
domestic cats from Australia with latent infection or fatal toxoplasmosis  
Aims: 
To determine the genotypes of T. gondii which are associated with clinical disease and 
compare these to those found in non-clinical individuals 
3.1 Samples 
The samples used in this study were sourced from individuals that went through the 
post mortem scheme at University Veterinary Teaching Hospital Sydney from March 
2014-April 2015. 
A 50g sample of muscle (usually gracillis), brain (from the occipital lobe), spleen, liver, 
kidney, lymph nodes, pancreas and lung were routinely collected from each individual. 
To prevent contamination during sampling, new gloves, scalpel blades and sterile tubes 
were used for each sample and instruments were wiped down with ethanol between 
each sample. If gross pathology was present- or in the case of previously unwell 
individuals, clinical signs suggested potential toxoplasmosis- then a 50 g sample of the 
associated organ was collected. These samples were stored at -80°C until analysed. 
When possible blood was taken from individuals and a Toxoplasma IFA was performed 
to determine whether they had been exposed to the parasite. 
As part of the routine post mortem process, tissues exhibiting pathology or tissues 
which potentially reflected ante-mortem signs were submitted for histology. If 
toxoplasmosis was suspected due to the presence of trophozoites and protozoal cysts T. 
gondii specific immunohistochemistry was performed on these tissues.  
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IHC staining for T. gondii antigen was performed using T. gondii epitome specific rabbit 
polyclonal antibody 1:1000 dilution according to previously reported techniques (RB-
282-A; Thermo Fischer Scientific, Fremont, CA, US) (Lindsay et al., 2010) 
3.2 DNA extraction 
In order to minimise contamination between samples only one individual was analysed 
at a time.  
DNA was extracted from each sample using DNeasy kit and a QIACUBE according to 
manufacturer instructions (DNeasy Blood and Tissue kit and automated processor 
QIACUBE; QIAGEN Germantown, MD). Three 25 mg samples of brain, muscle, lung and 
diseased tissue (if available and/or relevant) from each individual were weighed out 
and placed into sterile tubes. To reduce contamination, the extraction area was sprayed 
down with ethanol. A new scalpel blade was used for each 25 mg tissue and the petri 
dishes which were used to weigh them were changed between each organ.  180 µl of 
ATL and 20 µl of Proteinase K were added to each tube and also to an empty tube for a 
negative control. The solutions were mixed by vortexing and incubated at 56°C until the 
tissue was completely lysed (usually 5-6 hours). Once lysis was complete samples were 
transferred to a QIACUBE and the rest of the extraction process was carried out 
according to the DNeasy Animal Blood and Tissue program. DNA was eluted into 200 µl 
of AE buffer by the QIACUBE and the amount of DNA in each elution was quantified 
using a spectrophotometer. 
To determine whether DNA extraction was successful spectrophotometry was 
performed using a (Nanodrop 2000, Thermo Fisher Scientific, Australia). One microliter 
of elution buffer (AE) was used as a blank and one µl of DNA elution was loaded onto a 
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cuvette to measure the quantity of DNA in each extraction. The concentration (ng/µl) 
was recorded as well as the purity of the DNA sample.  
3.3 Polymerase Chain reaction 
- Detection of housekeeping gene (GAPdH) to confirm that the correct DNA was extracted   
To confirm that the correct DNA had been extracted a PCR which amplified the feline 
housekeeping gene GAPDH was used. Each 50 µl reaction contained 5 µl of 10x PCR 
buffer, 10mM dNTP, 75 mM MgCl2, 10 pmol of each primer, 0.2 U of Taq QIAGEN DNA 
Polymerase (QIAGEN Germantown, MD) and 1 µl of template. 
The products were visualised on a 1.5% agarose gel 
-Detection of T. gondii in each sample 
To detect T. gondii DNA in each non-clinical sample a nested PCR was used to amplify 
the 530bp B1 locus. Each 25 µl PCR reaction mixture contained 2.5 µl of PCR buffer, 
15mM MgCl2, 5 pmol of each primer and 0.2 U of Taq QIAGEN DNA Polymerase 
(QIAGEN Germantown, MD) and 1 µl of DNA template. Cycle conditions for the two 
rounds of PCR were: initial 95°C for 4 min, followed by 35 cycles of 94°C for 30 s, 60°C 
for 1 min and 72°C for 2 minutes.  PCR products from the first round were diluted by 
1:20 before proceeding to the second round.  This diagnostic test was performed on 
each of the four samples taken from each tissue four times (Appendix 1). The products 
of the PCR were visualised on a 1.5% agarose gel. The tissue sample which had the most 
consistent positive result was used in the next step. 
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3.4 Multiplex PCR 
Strain typing was performed using a multiplex PCR which amplified the genetic markers 
SAG1, 5’SAG2, 3’SAG2, altSAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, alt.SAG2, 
and Apico and was followed by a nested PCR as described previously (Su et al., 2006, 
2010). 
Multiplex PCR was performed on the samples that were consistently positive for T. 
gondii DNA according to the B1 diagnostic PCR.  Each 25 µl reaction contained 12.5 µl of 
MyTaq Red Mix (Bioline, Australia), 0.38µl of each primer and 2 µl of template DNA. 
Cycle conditions for the multiplex were initial 95°C for 4 min, followed by 30 cycles of 
94°C for 30 s, 55°C for 1 min and 72°C for 2 min. 
Following the multiplex PCR, the products were diluted 1:1 using UltraPure Distilled 
Water (Invitrogen, California, United States) and a nested PCR was performed. Each 25 
µl contained 12.5 µl MyTaq Red Mix (Bioline, Australia), 0.30 mM each of internal 
forward and reverse primer and 1.5 µl of multiplex PCR diluted product. The reaction 
mixture was then treated at 95°C for 4 min, followed by 35 cycles of 94°C for 30 s, 60°C 
for 1 min and 72°C for 1.5 min.  
Once the amplification process was complete, PCR products were bi-directionally 
sequenced using amplification primers (Macrogen Inc., Seoul, South Korea). The results 
were analysed on CLC bio (version 7). 
58 
 
3.5 Sequence analysis 
Chromatograms were visually verified using CLC Main Workbench Version 7.0.2 
(QIAGEN, CLC bio, Aarhus, Denmark). Virtual RFLP was performed using NEB-
Cutter1and results were compared to the same reference sequences (Gajria et al., 2008).  
 
Double peaks were detected using the “secondary peak calling” function on CLC Main 
Workbench 7.0.2. A cut-off of 20% of the maximum peak height was chosen for both 
forward and reverse sequences prior to assembly to a reference sequence. 
 
 Single nucleotide polymorphisms (SNPs) at the multiple copy B1 locus were identified 
by detection of double peaks at a single nucleotide position and then compared to the 
reference sequence (GenBank accession no. AF179871). Sequences were deposited in 
ToxoDB (EuroPathDB; http://toxodb.org/toxo/) and Genbank (NCBI, Genbank accession 
numbers KT881313 - KT881388). 
 
When data from all 13 loci were available the samples were given a ToxoDB number 
(http://toxodb.org/toxo/). If data from  all loci were not available a ToxoDB number or 
selection of numbers were given based on the data available.  
The following measures were taken to prevent external and cross contamination: 
1.       Sample collection 
At the time of sample collection, gloves were worn and the animal’s fur was wet to 
prevent contamination from the fur. Gloves and scalpel blades were changed between 
                                                          
1 New England Biolabs Inc. See: http://tools.neb.com/NEBcutter2/index.php 
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each organ and the forceps used to hold tissue were washed with 70% Ethanol. All 
instruments and garments were changed if more than one animal was being sampled at 
a time. 
The samples were stored in separate sterile containers stored at -80°C in a freezer 
which was located in an area away from PCR products. 
2.       DNA isolation 
To prevent cross contamination, DNA was extracted from one animal at a time. Gloves 
and scalpel blades were changed between each individual 25 mg sample and a separate 
petri dish was used each time to weigh out the sample.  The entire extraction process 
was carried out in an area away from PCR processes and gel stations. During the 
addition of Buffer ATL and Proteinase K, a new tip was used for each tube and the 
pipette was washed down with ethanol prior to use. This pipette was also one which 
had never been in contact with PCR products. Tubes were spun down prior to opening 
to prevent aerosolised contamination. 
To confirm that no contamination had occurred during this process, a negative control 
which had Buffer ATL and Proteinase K added was also put through the program in the 
QIACUBE. 
3.       PCR preparation 
To prevent the contamination of primers and the master mix, each reagent was 
aliquoted into smaller volumes (200-500 µl depending on the reagent) and spare 
aliquots were stored in a separate area. 
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All procedures prior to DNA addition were carried out in a sterile fume hood which was 
decontaminated for 20 minutes prior to work using UV light. 
Pipettes used for PCR preparations were only ever used within the fume hood and, 
therefore never come into contact with any DNA.  
New gloves were used for each preparation and UltraPure Distilled Water (Invitrogen, 
California, USA) was used in each reaction and dilution. Tubes were kept closed when 
nothing was being added to them. 
4. DNA addition/ dilution for PCR 
To prevent contamination of the workspace, tubes were spun down prior to opening 
and the surface was wiped down with ethanol and exposed to UV light prior to work. 
The pipette tip used was changed between each addition of DNA and pipettes were 
exposed to UV light for 20 minutes and wiped down with ethanol after each addition. 
Only one animal was analysed using the multiplex and nested protocol at a time and a 
new diagnostic PCR was left until these analyses were complete. 
Once the DNA had been added to each tube the tube remained sealed until gel analysis 
was required. 
5.       Diagnostic gel 
Gel analysis was carried out in a space separate to PCR thermocyclers.  Gel specific 
pippetes were used and the tips were changed between each tube. Tubes were kept 
closed at all times unless they were being used. 
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Gels were only run if no further PCRs were to be carried out that day due to the 
significant contamination risk that they pose. 
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 Abstract  
Associations between genotype and virulence of Toxoplasma gondii have been detected 
in experimental infections in mice. Little is known about whether genotype is associated 
with severity of disease in naturally occurring toxoplasmosis in domestic cats, or about 
the population structure of T. gondii in Australia. The aim of this study was to compare 
genotypes of T. gondii in latently infected cats with those from cats with fatal 
toxoplasmosis.  
A diagnostic PCR targeting the B1 gene was performed to detect T. gondii DNA and was 
positive in 11 (65%) cats, of which four had severe active toxoplasmosis and seven had 
latent infection, as confirmed by histologic findings and immunohistochemistry. 
Parasite DNA concentrations were adequate for genotype determination in all four cats 
with toxoplasmosis and in three of the latently infected cats using multi-locus PCR-RFLP 
including 11 loci (SAG1, 5’-SAG2 and 3’-SAG2, alt.SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, 
L358, PK1 and Apico) and direct sequencing of a multi-copy B1 marker. A non-
archetypal type II T. gondii strain (ToxoDB genotype #3) was detected in all seven cats. 
In the other latently infected cat, due to low DNA concentration,  partial genotyping 
using six loci was performed and it identified a Type II-like strain. Novel B1 gene 
polymorphisms were present in two strains and B1 gene polymorphisms unique to 
Australia were identified in another. One cat was co-infected with two or more strains. 
In natural feline infections in Australia, the genotype of T. gondii does not appear to be a 
major determinant of disease progression.  
 
Keywords: Feline; Genotype; Toxoplasma gondii; Toxoplasmosis; Australia 
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4.1. Introduction  
Toxoplasma gondii infections in owned domestic cats are usually subclinical and severe 
toxoplasmosis is uncommon, as reflected by high serological exposure rates of 
approximately 30% among healthy pet cats (Haddadzadeh et al., 2006; Liu et al., 2014; 
Vollaire et al., 2005). In Finland and Denmark, 3.1% (6/193) and 3.2% (5/155), 
respectively of cats undergoing necropsy were diagnosed with disseminated 
toxoplasmosis (Henriksen et al., 1994; Jokelainen et al., 2012) on the basis of 
histologically detectable disease. Congenitally infected kittens and 
immunocompromised cats are most susceptible to fatal toxoplasmosis (Barrs et al., 
2007; Davidson et al., 1993b; Dubey, 1982). Rarely, healthy cats with no detectable 
immune deficits or comorbidities develop severe clinical toxoplasmosis. Predisposing 
factors in these cases are not well understood.  
 
The severity of clinical disease in an infected host can be influenced by T. gondii 
genotype, however, little is known about whether specific genotypes are over-
represented in cats with naturally occurring clinical disease (Su et al., 2002; Carme et al, 
2002; Miller et al., 2004). Experimental infections in mice have shown differences in 
virulence between clonal types of T. gondii. Type I infections are fatal while infections 
caused by Types II and III are less severe (Howe et al., 1996; Sibley and Boothroyd, 
1992; Su et al., 2002). Microsatellite DNA analysis,  multilocus PCR-RFLP genotyping 
and genome analysis have demonstrated high genetic diversity of T. gondii with striking 
geographical hotspots of diversity such as South America (Shwab et al., 2014). Healthy 
cats have been found to carry a number of genotypes of T. gondii with regional specific 
distribution: a  non-clonal genotype termed Chinese 1 (ToxoDB PCR-RFLP genotype #9) 
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was most prevalent in the tissues of stray cats in China (28/35 cats sampled) (Qian et 
al., 2012; Tian et al., 2014; Yang et al., 2015) while in European stray and pet cats, clonal 
Type II (ToxoDB  genotype #1) was most common (82%,  124/151 cats sampled) (Can 
et al., 2014; Montoya et al., 2008). 
 
The aim of this study was to compare the genotypes of T. gondii in latently infected cats 
with those from cats with fatal toxoplasmosis. We applied multi-locus PCR-RFLP 
genotyping based on a previously established panel of 11 single locus markers (Su et al., 
2010) and the multi-copy B1 marker (Grigg and Boothroyd, 2001). We utilised recent 
cases of clinical and latent infections of Toxoplasma gondii in Australian cats undergoing 
a post-mortem examination and histopathological investigation.   
 
2.Materials and methods  
2.1 Sample collection 
Samples were sourced prospectively from cats undergoing post-mortem examination at 
the University Veterinary Teaching Hospital Sydney (UVTHS) (n=28) from March 2014 
to April 2015, with owner consent and approval from the University of Sydney Animal 
Ethics Committee (N00/7-2013/3/6029). Archived frozen tissues from a cat 
euthanased due to systemic toxoplasmosis in 2011 were also included.  Multiple tissue 
samples including appendicular skeletal muscle, forebrain, liver, and lung were 
collected in 10% neutral buffered formalin for histopathological examination and also 
frozen at -80 °C for subsequent DNA extraction. Serology to detect T. gondii specific IgG 
was performed after collection of heart blood from cats of unknown T. gondii serostatus 
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(IDEXX NSW, Australia). Histological examination of formalin fixed paraffin embedded 
tissue specimens was performed after routine haemotoxylin and eosin (H&E) staining. 
Immunohistochemical (IHC) staining for T. gondii antigen was performed using T. gondii 
epitope-specific rabbit polyclonal antibody at 1:1000 dilution (RB-282-A; Thermo 
Fischer Scientific, Fremont, CA, US) (Lindsay et al., 2010).  Data was extracted from the 
medical records of each patient including signalment, medical history and serological 
test results for feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) 
(IDEXX SNAP Combo) (Table 4.2).  
 
2.2 Definitions 
For each case, T. gondii  infection was classified as latent or active (clinical 
toxoplasmosis). Active infection was confirmed if protozoal cysts and/or tachyzoites 
and associated inflammation were identified on histological examination of one or more 
tissues and if parasite identity was confirmed as T. gondii by positive IHC labelling. 
Latent infection was defined as a positive anti-T. gondii IgG titre and the absence of 
inflammation-associated protozoal cysts or zoites on histopathological and 
immunohistochemical examination of multiple tissues. 
 
2.3 DNA extraction 
DNA was extracted from muscle, lung, liver and brain tissues (DNeasy Blood and Tissue 
kit and automated processor QIACUBE; QIAGEN Germantown, MD). To increase the 
likelihood of T. gondii detection, DNA was extracted from three tissue aliquots (25 mg) 
of each tissue type. All reactions included two negative controls: molecular grade water 
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(Life Technologies, Scoresby, VIC, Australia) (25 µl) and a DNA negative extraction 
control.  DNA from each tissue sample was quantified and checked for purity using a 
spectrophotometer (Nanodrop 2000, Thermo Fisher Scientific, Australia). For each 
tissue, the presence of amplifiable feline genomic DNA was confirmed using a GAPDH 
PCR (Beatty et al., 2014).  
2.4 B1 Diagnostic PCR and genotyping 
For detection of T. gondii DNA, a diagnostic PCR to amplify the 530 bp B1 locus was 
performed on the three DNA samples extracted from each tissue type (liver, lung, 
muscle and brain,) as described previously (Parameswaran et al., 2010). In order to 
minimise the potential for cross-contamination, genotyping was performed on only one 
case at a time. The genotype of T. gondii DNA detected in the diagnostic B1 PCR was 
determined using a multi-locus nested PCR to amplify the genetic markers B1, SAG1, 
5’SAG2, 3’SAG2, altSAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, alt.SAG2, and Apico 
(Grigg and Boothroyd, 2001; Su et al., 2010).  PCR products were sequenced bi-
directionally using amplification primers (Macrogen Inc., Seoul, South Korea). Forward 
and reverse sequences were aligned to reference clonal Type strains I (GT1; ToxoDB 
genotype #10), II (Me-49; ToxoDB genotype #1) and III (VEG; ToxoDB genotype #2) 
(Gajria et al., 2008). Chromatograms were visually verified using CLC Main Workbench 
Version 7.0.2 (QIAGEN, CLC bio, Aarhus, Denmark). Virtual RFLP was performed using 
NEB-Cutter and results were compared to the same reference sequences (Gajria et al., 
2008). Dinucleotide peaks were detected using the “secondary peak calling” function on 
CLC Main Workbench 7.0. 2 with the default cut-off of 20% of the maximum peak height 
for both forward and reverse sequences prior to assembly to a reference sequence. 
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 Single nucleotide polymorphisms (SNPs) at the B1 locus were identified by detection of 
dinucleotide peaks at a single nucleotide position and then compared to the reference 
sequence (GenBank accession no. AF179871). Sequences were deposited in ToxoDB 
(EuroPathDB; http://toxodb.org/toxo/) and Genbank (NCBI, Genbank accession 
numbers KT881313 - KT881388). 
3. Results   
3.1 Cats with T. gondii infection  
Tissue samples were collected at post-mortem from 28 cats, especially targeting cats for 
which T. gondii serostatus was known or where toxoplasmosis had been diagnosed 
antemortem.  Seventeen cats were seropositive for  T. gondii. In three cats with active 
toxoplasmosis, only liver or lung or brain was available for genotyping.  
Table 4.1 B1 PCR results for each tissue tested in triplicate and visualised on a 1.5% 
agarose gel. 
Cat Active/Latent Muscle Lung Liver  Brain 
1 Latent ---/+-+/+++ 0 0 +--/-+-/+--- 
2 Latent ---/---/--+ -+-/+--/--+ 0 ---/+--/--- 
3 Latent 0 0 ++-/+++/--- 0 
4 Latent +++/+++/--- +++/+++/+++ ++-/+-+/+++ -++/+++/+-- 
5 Active n/a +-+/+++/+-+ 
6 Active n/a +++/+++/+++ n/a 
7 Active +++/+++/+++ +++/+++/+++ +++/+++/+++ +++/+++/+++ 
8 Active n/a  +++/+++/+++ n/a 
9 Latent 0 0 0 -+-/---/--- 
10 Latent 0 +--/---/--- 0 0 
11 Latent  +--/+--/+-- 0 0 0 
Note: “+” indicates the presence of a band, “-“ indicates the absence of a band, “0” indicates no T. 
gondii DNA found in that tissue and each triplicate is separated by a “/”. Cats 1-8 were used for further 
genotyping however cats 9-11 had insufficient T. gondii DNA to perform high resolution genotyping. 
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 Diagnostic PCR for the T. gondii B1 gene was  positive in tissue samples from 11 of the 
17 seropositive cats tested  (65%) including seven cats with latent infection and four 
cats with active toxoplasmosis  (Tables 4.1 and 4.2). Four seropositive cats with 
negative B1 PCR results were excluded from further study.  
 Of the four cats with active infections,  toxoplasmosis was diagnosed antemortem  in 
two cats. In one of these, an FIV positive (not vaccinated for FIV) nine year old male 
castrated domestic shorthair cat,  that had presented with a  4-day history of lethargy, 
anorexia and jaundice, tachzyoites were detected in cytological preparations of liver 
from an ultrasound-guided fine-needle aspirate (Cat 7, Tables 4.1 and 4.2). Despite 
treatment with clindamycin (Dalacin, Pfizer 12.5 mg/kg IV q 12 h) and pyrimethamine 
(Daraprim, Aspen Pharmcare 1 mg/kg PO q 12 h) the cat developed respiratory distress 
after two days and was euthanased. Post-mortem examination findings confirmed  
severe disseminated toxoplasmosis.  In the other case, a four-year old male castrated 
Burmese cat receiving immunosuppressive therapy (prednisolone 1mg/kg q 24 h PO, 
Apex Laboratories;  cyclosporin 6 mg/kg q 24 h PO, Atopica, Novartis) for a severe 
chronic inflammatory polyarthropathy, was presented for an acute onset of 
inappetence, lethargy and fever. Tachyzoites were detected in cytological preparations 
of pleural fluid and lung  (Cat 8, Tables 4.1 and 4.2). Fungal hyphae were also detected 
in lung and pleural fluid cytology. Culture of lung yielded a phaeohyphomycosis, 
Cladophialophora bantiana and concurrent bacterial pneumonia due to Salmonella 
infantis, identified at the National Mycology Reference Laboratory Adelaide, and the 
Salmonella Reference Laboratory, Adelaide, respectively. The cat was euthanased. Post-
mortem findings included mycotic encephalitis and pneumonia and disseminated 
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toxoplasmosis with involvement of lung,  cerebellum, adrenal gland and mesenteric 
lymph nodes. 
In two cats, including a seven year female neutered domestic longhair cat that 
presented with jaundice, active toxoplasmosis was diagnosed post-mortem,. The cat had 
been treated for four months with multiagent chemotherapy for hepatic lymphoma and 
was thought to be out of remission and euthanased.  The owner consented to a limited 
post-mortem to obtain a liver biopsy. Histological findings confirmed recurrent hepatic 
lymphoma and severe toxoplasmosis (Table 4.2). In the other cat, a four year old male 
castrated domestic shorthair cat with  a three-month history of progressive 
neurological findings including ataxia, circling and difficulty swallowing, neurological 
examination revealed the presence of multiple cranial nerve deficits. Diffuse or 
multifocal CNS disease was suspected, and due to disease severity and financial 
constraints the cat was euthanased. On post-mortem examination, the cat was found to 
have severe non-suppurative encephalitis associated with T. gondii  infection and no co-
morbidities. Protozoal cysts with associated inflammation and necrosis were detected 
in brainstem, cerebrum, cerebellum, cervical spinal cord and kidney  (Cat 5, Tables 4.2 
and Figure 4.1). 
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Table 4.2 Patient characteristics of cats seropositive for T. gondii with latent infection or active clinical toxoplasmosis 
No. Signalment Immuno-
histochemical 
labelling for T. 
gondii 
Infection 
type 
Tissue 
genotyped 
FIV 
serology 
FeLV 
serology 
Immuno-
suppressive 
medications 
Diagnoses and  Post-mortem 
findings 
1 12 y MN 
Oriental 
shorthair 
No T. gondii 
detected 
Latent Muscle Negative Negative None Diabetic ketoacidosis 
Severe chronic pancreatitis 
Lymphoplasmacytic enteritis 
Chronic rhinosinusitis 
 
2 11 y FS DSH No T. gondii 
detected 
Latent Lung Negative Negative Multi-agent 
chemotherapy 
Nasal and retrobulbar lymphoma, 
out of remission 
 
3 6 y MN DSH No T. gondii 
detected 
Latent Liver Positive Negative None Pancytopenia 
Acute myeloid leukemia 
 
4 11 y MN DSH No T. gondii 
detected 
Latent Liver Negative Negative None Chronic pancreatitis 
 
5 4 y MN DSH Positive labelling 
of  protozoal 
tissue cysts in 
CNS and kidney 
Active Brain Negative Negative None Multiple cranial nerve deficits and 
ataxia. 
Severe necrotising non-suppurative 
diffuse encephalitis (brain-stem) 
with free and intracellular 
protozoal cysts. Protozoal cysts 
also detected in cerebrum, 
cerebellum, cervical spinal cord 
and kidney 
Disseminated toxoplasmosis 
 
6 7 y FS DLH Positive labeling 
of protozoal cysts 
and tachyzoites 
in liver 
associated with 
severe necrosis 
and inflammation 
Active Liver Negative Negative Vincristine 
Cyclophosphamide 
Prednisolone 
Extrahepatic portosystemic shunt 
Hepatic lymphoma 
Hepatic toxoplasmosis 
72 
 
7 9 y MN DSH 
 
Positive labeling 
of protozoal cysts 
and tachyzoites 
in tissues stained 
(liver and brain).  
 
Active Liver Positive Negative None Multi-organ inflammation and 
necrosis, including liver, heart, 
brain, kidneys and pancreas 
Disseminated toxoplasmosis 
8 4 y MN Burmese Positive labeling 
of protozoal cysts 
and tachyzoites 
in lung, colon and 
adrenal gland in 
association with 
necrosis and 
inflammation. 
Active Lung Negative Negative 
 
Prednisolone 
Cyclosporine 
Severe inflammatory polyarthritis 
Mycotic pneumonia 
(Cladophialophora bantiana) 
Disseminated toxoplasmosis  
 
73 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Lesions in cat 5, an active case infected with Toxoplasma gondii nonarchetypal type II-like strain. A) Protozoal cyst 
and inflammatory infiltrate associated with necrosis in the brain stem (haemotoxylin and eosin stain). B) Immunohistological 
staining of aggregated T. gondii tachyzoites in the brain stem. Scale bars A, B and C- 20µm 
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3.2 T. gondii genotypes in cats with active and latent infection 
 
Genotyping of T. gondii strains by PCR-RFLP was performed in eight of  the 11 cats that 
tested positive on the B1 diagnostic PCR.  T. gondii DNA concentrations in tissues from 
the four remaining cats were inadequate for PCR-RFLP despite repeated attempts. 
Based on serological, histopathological and IHC results, four cats were latently infected 
with T. gondii (Cats 1-4) and four had active toxoplasmosis (Table 4.2).  In seven cats, 
Type II alleles were identified at SAG1, 5’-SAG2, alt.SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, 
L358 and PK1 loci and a type I allele was found at the Apico locus. Accordingly, these 
isolates were assigned the genotype ToxoDB genotype #3 (Type II variant), which 
differs from ToxoDB # genotype #1 (clonal Type II) only at the Apico locus (Table 4.3). 
In five cats, Type II alleles were present at the B1 locus, while in three cats non-
archetypal alleles were detected (Table 4.4). 
 In one cat, sequences were obtained for six loci. Due to the presence of type II alleles at 
3’-5’-SAG2, alt SAG2, L358 and SAG 3 possible genotypes includeToxoDB#1, #3, #128 or 
#129 (Cat 4, Table 4.3).    
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Table 4.3 Summary of the genotypes found in the cats in the present study. 
 B1 C22-8  GRA6  C29-2  L358  PK1  alt.SAG2 SAG1  3'SAG2  5’SAG2  SAG3  BTUB  Apico  Genotype 
Type I 
(GT1*)  
I I I I I I I I I I I I I ToxoDB#10 
Type II 
(ME49*)  
II/III II II II II II II II/III II II II II II ToxoDB#1 
Type III 
(CTG*)  
II/III III III III III III III II/III III III III III III ToxoDB#2 
1 II/III II II II II II II II/III U-1a,c II II II I ToxoDB#3 
2 II/III II II II II II II II/III II II II II I ToxoDB#3 
3 U-Xc II II II II II II II/III II II II II I ToxoDB#3 
4 U-Yc nd nd nd U-1c nd II nd U-2c II II nd nd ToxoDB#1 
5 II/III II II II II II II II/III II II II II I ToxoDB#3 
6 U-6b II II II II II II II/III II II II II I ToxoDB#3 
7 II/III II II II II II II II/III II II II II I ToxoDB#3 
8 II/III II II II II II II II/III II II II II I ToxoDB#3 
Note: *Genotype determined from ToxoDB v11 sequences (Gajria et al. 2008) 
a- A mixed infection was found at this allele with two or more similar type II-like strains 
b- B1 gene dinucleotide calling parameters: fraction of maximum height peak = 0.2 in CLC Main Workbench v7.0.2 and visual confirmation (see text, Fig. 3) 
c- novel alleles unique to this study  
nd- no data 
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3.3 Polymorphisms and dinucleotide peaks found 
   
Single nucleotide polymorphisms (SNPs) were identified in the single copy locus  
3’SAG2 in two cats (Table 4.4). Cat 1 at nucleotide position 1222 and 1275 in muscle 
tissue (GenBank accession no. AF249697.1) and Cat 4 at nucleotide position 1205 in 
liver. Cat 4 also had a SNP in the L358 at allele at nucleotide position 199 from liver 
tissue (Genbank accession no. KM246835.1) (Table 4.4). Dinucleotide peaks were 
detected at the single copy 3’SAG2 locus at nucleotide position 1222 and 1275 in Cat 1 
from the same muscle sample, consistent with the presence of more than one non-
archetypal Type II strain (Table 4.4). PCR-RFLP was repeated for this locus on two 
subsequent muscle sections from Cat 1 and the same results were obtained for 
nucleotide position 1275 but not for 1222. The SNPs in Cat 1 and Cat 4 were not at 
restriction sites and did not change the fragment length when analysed with NEBCutter. 
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Table 4.4 Polymorphisms found in the B1, 3’SAG2 and L358 locus  
Marker 
B1 
 
3'SAG2  L358 
Nucleotide 233 366 378 504 595 Allele 
 
1205 1222 1275  Allele 
 
199 Allele  
Consensus  C C/T G G/C T     A G G   
 T  
GTI (Type I) G T . G . I 
 
G G . I 
 
. I 
ME-49 (Type 
II) . . . . . II 
 
. . . II 
 
. II 
CTG (Type 
III) G . . . . III 
 
. . . III 
 
. III 
Cat 1 . . . . . II/III 
 
. G/C A/G U-1a,c
 
 
 
. II 
Cat 2 . . . . . II/III 
 
. . . II  . II 
Cat 3 . T . . . U-Xc 
 
. . . II 
 
. II 
Cat 4  G C . G C U-Yc  G . . U-2c 
 C U-1c 
Cat 5 . . . . . II/III 
 
. . . II 
 
. II 
Cat 6 . . G/A
b
 . . U-6 
 
. . . II 
 
 . II 
Cat 7  .   . . . . II/III   .  . . II  . II 
Cat 8 .   . . . . II/III   .  . . II  . II 
 
 
  
 
Note: Sequence residues correspond to reference sequence from Genbank: AF179871, AF249697.1 and KM246835.1 
respectively. Sequence residues for samples from this study can be found with the Genbank accession numbers  
a -A mixed infection was found at this allele with two or more similar type II-like strains 
b- B1 gene dinucleotide calling parameters: fraction of maximum height peak = 0.2 in CLC Main Workbench v7.0.2 and visual 
confirmation (see text, Fig. 3) 
c-novel alleles unique to this study 
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When compared to the reference B1 sequence (Genbank accession number AF179871), 
SNPs were identified in Cat 6 at nucleotide position 378 and in Cat 4 at positions 233 
and 595 (Table 4.4). Dinucleotide peaks were detected in the B1 locus at position 366 in 
all cats except Cat 3 and Cat 4, at nucleotide position 504 in all cats except Cat 4 and at 
nucleotide position 378 in Cat 5 (and Table 4.4).  
 
4. Discussion 
 
This is the first study to characterise the genotypes of T. gondii in Australian cats where 
disease status (active versus latent infection) was definitively identified. Type II variant 
(ToxoDB genotype #3) was identified in cats with asymptomatic latent infection and in 
cats that died or were euthanased due to severe active toxoplasmosis. While the 
findings in this study do not rule out the possibility that certain genotypes may be more 
virulent than others in cats, they suggest that factors that influence host susceptibility 
are more common determinants of clinical disease severity. Of the four cats with active 
clinical toxoplasmosis, three had immunosuppressive diseases or had been 
administered immunosuppressive medications, including one cat with lymphoma on 
chemotherapy, one cat treated with cyclosporine and prednisolone for an immune-
mediated polyarthropathy, and one cat with FIV infection (Table 4.2). Only one cat with 
active toxoplasmosis had no identifiable co-morbidities. It is possible that, as in humans, 
variations in immune genes such as the major histocompatibility complex (MHC) could 
be associated with increased susceptibility to toxoplasmosis in cats. The frequency of 
the MHC class II human leucocyte antigen gene DQ3 was significantly higher in 
congenitally infected infants with hydrocephalus than in infected infants without 
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hydrocephalus or than in the general US population (Mack et al., 1999). Transgenic 
murine studies confirmed these findings, mice with the human DQ3 gene had a higher 
tissue cyst burden when infected orally with T. gondii tissue cysts than mice with the 
related human DQ1 gene (Mack et al., 1999). 
 
Although experimental studies in cats have found associations between T. gondii 
genotype and disease severity, differences among studies in the inoculum dose, 
infecting stage (tachyzoites, oocysts or bradyzoites) and route of infection could be 
confounding variables. Experimental studies designed to investigate disease 
pathogenesis often involve parenteral inoculation of tachyzoites or oocysts and are not 
representative of natural infection. Correlations between virulence and genotype are 
likely to be most applicable in experimental studies where the route of inoculation, life-
stage of the parasite and inoculum dose mimics natural infection (Lappin et al., 1996; 
Omata et al., 1994; Powell and Lappin, 2001).  
 
Congenital or lactational infection of kittens by Type II strains (Maggie, Mozart, and ME-
49) is consistently associated with the development of ocular lesions (chorioretinitis), 
of which the Mozart strain is most oculotropic (Powell et al., 2001; Powell and Lappin, 
2001). Ocular lesions with few or no other clinical signs have also been induced in cats 
experimentally by intra-carotid inoculation with Type II strain tachyzoites (ME-49) 
(Davidson et al., 1993a; Davidson et al., 1993b). However, the Type II strain ME-49 has 
also been documented to cause occasional fatal disease in cats after oral inoculation of 
tissue cysts (Dubey, 1995b; Powell and Lappin, 2001). Intravenous inoculation of cats 
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with Type I tachyzoites (RH strain) into the jugular vein, consistently resulted in acute 
disseminated fatal infections (Parker et al., 1981).  
 
The infecting strain of T. gondii has been genotyped in only eight other cases of clinical 
toxoplasmosis in cats (Dubey and Powell, 2013; Jokelainen et al., 2012; Spycher et al., 
2011). In contrast to this study where ToxoDB genotype #3 was identified in all cats 
with active infections, this same genotype has only been detected in one other case of 
naturally occurring feline disease, in a cat from Switzerland (Spycher et al., 2011). In 
that case, similar to Cat 5 in this study, concurrent disease was not identified and 
immunosuppressive drugs had not been administered. Other genotypes that have been 
detected in cats with toxoplasmosis include Type 12 clonal (ToxoDB genotype #4, n=1) 
in one cat in the United States and clonal Type II (ToxoDB  genotype #1) in six cats in 
Europe (Dubey and Powell, 2013; Jokelainen et al., 2012).The infecting strains in these 
cases were of a genotype endemic to the area which the cats had come from and had 
also been detected in healthy feline hosts without signs of toxoplasmosis (Herrmann et 
al., 2010) and other non-feline species (Dubey et al., 2011; Herrmann et al., 2013; 
Jokelainen et al., 2011).  
 
The high prevalence of the ToxoDB#3 genotype in this study suggests that it is endemic 
in Australia. It has also been identified in feline hosts worldwide and was highly 
prevalent among latently infected feral cats (51%) in Egypt and in pet cats with primary 
infections shedding oocysts (79%) in Germany (Al-Kappany et al., 2010a; Herrmann et 
al., 2010).  The ToxoDB #3 genotype is among the dominant genotypes found in Europe, 
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Africa and North America and is the second most frequently identified genotype of all 
hosts worldwide after the clonal Type II genotype (ToxoDB#1) (Shwab et al., 2014). 
Few other Australian isolates of T. gondii have been genetically characterised using high 
resolution molecular techniques (Figure 4.2). In contrast to the findings here, the most 
common genotype identified in other Australian studies was ToxoDB#1(clonal Type II ) 
from a seal, dog, goat, wallaby and two wombats (Al-Qassab et al., 2009; Donahoe et al., 
2014; Donahoe et al., 2015; Parameswaran et al., 2010). ToxoDB#10 (clonal Type I) was 
also identified in a cat and a goat (Parameswaran et al., 2010). Type III strains were 
reported in another Australian study, however since only 3 genetic loci (B1, SAG2 and 
SAG3) were used to type these strains (Pan et al., 2012), it is not possible to determine 
whether isolates had clonal Type III alleles at all loci or were recombinant strains 
(Chumpolbanchorn et al., 2013).  
 
 
 
 
 
 
 
 
 
Figure 4.2 The total number of Australian isolates of T. gondii for which genotyping of 11 loci as presented 
in this study have been performed. (Al-Qassab et al., 2009; Donahoe et al., 2014; Donahoe et al., 2015; 
Parameswaran et al., 2010; Shwab et al., 2014) and the present study) 
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The ToxoDB genotype #3 has been reported in Australia previously in two intermediate 
hosts, a wombat and a human (non-AIDS) patient (Donahoe et al., 2015; Shwab et al., 
2014; Sibley and Boothroyd, 1992). The wombat had active clinical toxoplasmosis with 
severe neurological signs. The true prevalence of this genotype in Australia is unknown 
since genetic characterisation of other Australian isolates did not include the Apico 
locus (Pan et al., 2012; Parameswaran et al., 2010). Thus, strains previously reported as 
“archetypal Type II” could be either ToxoDB#1 or ToxoDB#3 since these genotypes only 
differ at the Apico locus (Su et al., 2010; Su et al., 2006).  
 
The addition of the highly polymorphic B1 locus to the commonly used 11 multi-locus 
DNA markers is important for genotyping of Australian isolates of T. gondii because 
non-archetypal and Type II-like alleles have been found at this locus frequently 
(Donahoe et al., 2014; Donahoe et al., 2015; Pan et al., 2012; Parameswaran et al., 2010). 
Dinucleotide peaks at position 366 and 504 in the majority of cats are characteristic for 
Type II/III strains whereas the SNP at position 378 found in Cat 6 and at position 233 in 
Cat 4 are inconsistent with Type I, II or III strains (Table 4.4). The polymorphism found 
at 378 np at the B1 locus in Cat 6 represents a non-archetypal polymorphism which has 
been described previously in several Australian mammals (Parameswaran et al., 2010).  
 
This study found less diversity in T. gondii strains in owned domestic cats than has been 
previously reported among infected Australian wildlife, although it is possible this is a 
reflection of small sample size. Only two unique alleles were identified at the B1 locus in 
the cats in this study, whereas diversity in this allele was high in wildlife samples from 
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Western Australia (Pan et al., 2012; Parameswaran et al., 2010). Whether this reflects 
host differences or geographical region is not known and highlights the need for further 
investigation into the population structure of T. gondii in Australia.  
 
Mixed infections, as detected in Cat 1 (Table 4), were also found to be common among 
Australian wildlife (Pan et al., 2012). Cats can become multiply infected when they 
ingest prey infected with more than one strain, or when they ingest multiple infected 
prey over a short period during oocyst shedding. In feline hosts with two (or more) 
strains, there is potential for sexual reproduction to occur between strains. The non-
archetypal polymorphisms found in Cat 1 at 3’SAG2 represent novel polymorphisms at 
nucleotide positions 1222 and 1275 (Table 4.4) that are unique to this study.  
 
Cat 4 (Tables 4.2- 4.4) could only be partially genotyped, presumably due to low T. 
gondii DNA concentrations. Although this isolate could be one of four possible ToxoDB 
genotypes, it is most likely genotype #3 or #1, given the genotypes identified in the 
other cats here and previously in Australia. Similar difficulties genotyping latently 
infected cats using multi-locus PCR-RFLP have been reported previously (Tian et al., 
2014). A high degree of diversity was found in the loci that could be genotyped in Cat 4 
including novel SNPs at the B1, L358 and 3’SAG2 loci (nucleotide positions 233 and 595, 
199 and 1205, respectively Table 4.4).  When comparing the number of samples for 
which T. gondii DNA was consistently detectable by diagnostic PCR between cats with 
active or latent infection, overall T. gondii was detected most frequently and 
consistently in the tissues of cats with active infection (Table 4.1). Thus multi-locus 
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PCR-RFLP is well suited to detect and genotype T. gondii in cats with active infection, 
but can be problematic in latent infections. It is possible that the low sensitivity of the 
technique used for T. gondii DNA extraction in the present study may create a bias 
towards sampling genotypes which have a high parasite burden such that the true 
diversity of T. gondii may be underestimated (Costa et al., 2011). Genotyping of other 
seropositive latently infected cats in this study may have been more likely using 
techniques to concentrate T. gondii DNA such as mice bioassay.  
 
 5. Conclusions  
We have genetically characterised the strains of T. gondii in eight naturally infected cats 
from Sydney, Australia. There were few differences in the genotypes and diversity of 
infecting strains between cats with latent or active infection. The results confirm that 
host factors are of major importance in determining whether cats develop active 
toxoplasmosis.  
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Chapter 5: Further discussion and future directions   
 
The research presented in this thesis represents an important step in our 
understanding of T. gondii in Australia and also in feline infections generally.  
Chapter two describes a seroepidemiological study which measured the seroprevalence 
of T. gondii in owned domestic cats in Australia. This was the first study to evaluate cat 
lifestyle factors which increase the risk of exposure to T. gondii in Australian owned 
cats. Of the cats surveyed, 38% were seropositive, indicating that Australian cats are 
commonly exposed to the parasite. Raw beef and raw kangaroo in the diet and also 
rodent hunting were identified as risk factors for exposure. Surprisingly, outdoor access 
was not identified as a risk factor, however, this could be due to survey design and 
under reporting of outdoor access in pet cats. Future studies should consider this when 
designing a survey to collect data on cat’s lifestyles.  
Studies which aim to further investigate the seroprevalence of T. gondii in owned 
Australian cats should focus on expanding on the areas that are sampled as not all states 
are represented in the current study. The samples tested in Chapter two were sourced 
from veterinary hospitals in capital cities with the exception of 31 samples from Clinic 
10 in Townsville. Cats from rural areas in Australia may have different lifestyles to 
urban cats and are more likely to come into contact with feral cats which are a 
population that have high rates of exposure to T. gondii (Fancourt and Jackson, 2014). 
As such, investigation of the seroprevalence of T. gondii in rural cats is warranted as is 
likely to differ from rates found in urban cats.  
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Educating owners about the risk factors which were identified in Chapter two and 
encouraging them to address these risk factors with a focus on cat welfare could 
decrease the likelihood of cats being exposed to T. gondii in Australia.   
Currently there is no data on the prevalence of T. gondii in Australian cattle and very 
little is known about the prevalence of T. gondii in kangaroos from populations which 
are hunted for the meat industry. Given that these meats were identified as risk factors 
for T. gondii exposure in Australian cats in Chapter two, investigation into the 
prevalence of T. gondii and viability of T. gondii cysts (if present) in beef and kangaroo is 
needed to determine the exact risk not only to cats but also other species which 
consume raw beef and kangaroo, such as dogs and humans.   
Chapter Four describes cases of feline toxoplasmosis and also the results of the genetic 
characterisation of isolates of T. gondii found in cats with active and latent infections. In 
this chapter direct comparisons were made between genotypes found in active and 
latent feline infections in order to determine whether the severity of T. gondii infections 
in feline hosts is dictated by infecting strain. The research presented in this chapter 
represented the first case of feline toxoplasmosis in Australian cat to have the infecting 
strain genotyped.  
The non-archetypal type II T. gondii strain (ToxoDB genotype #3) which was detected in 
seven of the eight cats appears to be endemic to Australia and has been previously 
identified in Australian hosts. Naturally infected cats with active and latent infection 
were both infected with the same strain, indicating the infecting strain is not the major 
determinant of disease progression and that other host factors may be of greater 
importance. Future studies which assess the determinants of disease severity should 
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assess potential host immune factors which may have a greater impact than infecting 
strain.  
The research presented in Chapter Four added an additional seven isolates to the total 
number of isolates typed using high resolution techniques in Australia (n=17- Figure 
4.2). While this is a significant contribution, further investigation into genotypes which 
infect different host species and also felines from different areas is required to obtain a 
more robust picture of the population structure of T. gondii in Australia.   
Detection and characterisation T. gondii isolates in latently infected hosts is limited by 
the sensitivity of the technique presented in Chapter Four and also the availability of 
multiple organs as T. gondii cyst distribution is not uniform or organ specific.  Mouse 
bioassay could assist in concentrating DNA in these hosts. There is also potential for 
magnetic bead DNA capture to assist in T. gondii detection in latently infected hosts 
however currently there is no protocol which combines magnetic bead capture and the 
11 multi-locus RFLP markers exists.  
 
 
 
 
 
 
 
88 
 
Appendices 
 
 
Appendix 1. A schematic which demonstrates the aliquots taken from each tissue (pink boxes) and 
the triplicate diagnostic PCR which was performed on each aliquot  
 
  
Muscle Brain 
 
 
Tissue aliquot 2 
 
 
Tissue aliquot 1 Tissue aliquot 3 
B1 PCR products 
DNA Extraction  
B1 diagnostic 
PCR 
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Appendix 2. Survey give to owners to fill out regarding their cat signalment, diet and other lifestyle factors  
 
Please take a few minutes to fill out this survey that will help identify potential environmental risk 
factors for exposure to Toxoplasma gondii in cats. As you are aware, this is a parasite which can 
cause disease in cats however in most cases cats show no signs of being infected. Our group is 
performing research understand the risk factors that contribute to exposure to Toxoplasma gondii in 
Australian cats and also to determine what proportion of Australian cats have been exposed to this 
parasite.  
Date:  
Vet Clinic name and 
address: 
 
  
1. Information on your cat 
Age  
Breed   
Sex  □ Male □ Female   
Is your cat desexed? □ Yes □ No   
How old was your cat when 
you first got it? 
 
Where did you get your cat 
from? 
□ Breeder □ Pet shop □ Shelter □ Vet □ Online/other 
Post code where your cat 
lives  
 
Does your cat have any   
current illnesses?              
 
□ Yes □ No    
List illnesses                           
2. Environment  
Does your cat have 
any access to 
outdoors? 
□ Yes □ No  
 
Regarding outdoor 
access how would you 
describe it:  
 
 
 
 
☐ Indoors only  
☐ More indoors than outdoors  
☐ 50% indoors, 50% outdoors  
☐ More outdoors than indoors  
☐ Outdoors only  
 
Risk Identification Survey for toxoplasmosis in cats 
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If your cat has or had 
outdoor access is/was 
it  
☐ Enclosed run, courtyard or enclosed yard  
☐My cats outdoor access is not restricted to my property boundaries 
If your cat has/had 
outdoor access is/was 
it 
☐ Daytime only ☐ Night time only ☐ Day and night time 
Area lived in: ☐ Rural ☐Semirural ☐Urban 
Is your cat most active ☐ Daytime  ☐ Night-time ☐ Unknown 
    
Toileting habits ☐ Litter box only ☐ Both litter and 
outdoors  
☐ Outside only 
3. Diet 
The following statement best describes my cat’s diet (if applicable): 
☐ Totally (100%) wet food from cans or pouches  
☐ Totally (100%) dry food  
☐ A combination of commercial wet and dry food only  
☐ A combination of raw meat and commercial food  
☐ A combination of cooked meat and commercial food 
 
Do you ever feed your 
cat raw meat? 
□ Yes □ No    
If yes, how often? □ Daily □ Weekly □ Monthly ☐ Occasionally 
What types of raw meat have you fed your cat – tick all that apply   
 ☐ Chicken ☐ Beef  ☐ Lamb   ☐ Pork ☐Rabbit  
☐ Kangaroo ☐ Other    
Does your cat hunt? ☐  Yes 
(often) 
☐  Sometimes ☐  Never   
If yes, have you ever 
seen your cat eat the 
prey? 
☐ Yes ☐ No    
What prey have you seen your cat catch? Tick all that apply 
 ☐  Insects  
 
☐ Slugs or 
snails 
☐  Lizards ☐ Rodents ☐ Birds 
Does your cat ever go to 
boarding facilities? 
□ Yes □ No    
Do you have any other 
cats? 
□ Yes □ No    
91 
 
If yes, how many?     
If you would like to be contacted with the results of this study please let your 
veterinarian know 
 
Comments: 
 
 
  
 
 
  
Please be advised that your information will be stored securely and your identity/information will be kept strictly confidential, except as required by law. 
Study findings may be published, but you will not be individually identifiable in these publications. 
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Appendix 3. Standard Recipes used in the Toxoplasma specific IgG and IgM ELISA 
 
0.01M PBS:     85g NaCL 
     21.75g Na2HPO4●7H20  
     3.5 g Na2HPO4●1H20  
     QS made up to 10 L with deionised water 
 
PBS-Tween:    0.5 ml Tween 20 is added to 1000 ml PBS (0.01M) to make 
     up a 0.05% solution 
 
0.18 M H2SO4 (stop solution):  Stock solution used is 8N H2SO4 
44.8 ml of 36N H2SO4 was added to 175.2 ml deionised 
water to obtain 8N H2SO4 
The working solution is 0.18M H2SO4 
To make this 4.5 ml stock solution (8N H2SO4) was added to 
95.5 ml deionised water 
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Appendix 4. Creating a titre scale  
 
An example of the calculations necessary to create a titre scale is given below 
Firstly, the 1:64 titre cut off value is determined by calculating the average negative control 
absorbance and multiplying it by the multiplication factor.  
For example, if the average absorbance of the wells with the negative control was 0.258 and the 
multiplication factor for that plate was 2.3 then:  
0.258  x 2.3= 0.593  
To create the titre scale this value is subtracted from the average of the positive control wells (eg 
1.730) and divided by the number of titres between 1:64 and the predetermined positive titre (eg 
512) 
Average negative control absorbance X multiplication factor  
number of titres between the negative cut off and the positive titre 
So in this example;  
    0.593  = 0.197 
        3 
The value obtained from this equation was added to the 1:64 cut-off and then consecutively added 
thereafter to each titre bracket to give a value for each titre as below 
 
    0.593 (1:64) 
    0.972 (1:128) 
    1.351 (1:256) 
    1.730 (1:512) 
    2.109 (1:1024) 
    2.488 (1:2048) 
 
The titre of each suspect sample was determined by calculating the average absorbance of the four 
values obtained and then this value was aligned with a titre bracket calculated as above.  
For example, if the average absorbance of the triplicate for a particular sample is 0.677 that sample 
would be given the titre 1:64, if the average absorbance was 0.332 then that sample would be 
considered negative and if the average absorbance was 1.82 the titre would be 512.    
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